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HOW IS ENCYSTMENT REGULATED IN GIARDIA INTESTINALIS 
IRYNA G. TSARUKYANOVA 
ABSTRACT 
Giardia intestinalis is a protozoan parasite causing water-borne infection: giardiasis. 
The infective stage of the parasite is a cyst, protected from the environment by a cyst wall 
of protein and a complex polysaccharide called giardan.   
The initiation and the key for cyst wall biosynthesis is amination and isomerization 
of fructose 6-phosphate by glucosamine 6-phosphate deaminase (GNP). Fructose 6-
phosphate is also an intermediate in glycolysis, the main, but not the only energy 
producing pathway in Giardia. The alternative energy source is arginine which is 
metabolized through the arginine dihydrolase pathway. The latter pathway is up-
regulated upon encystment. However, the triggering mechanism is still unknown. The 
hypothesis developed and discussed in this dissertation is that the switch between 
glycolysis and cyst wall synthesis is a key point for encystment regulation and is 
controlled, at least in part by nitric oxide (NO).  
The discovery that Giardia is able to synthesize NO leads to the conclusion that it 
may use protein nitrosylation to regulate cellular differentiation in a similar way as it 
takes place in higher eukaryotes. This study aims to show that key proteins for glycolysis 
and the encystment pathway are posttranslationally modified by S-nitrosylation. The 
latter modification regulates protein activity and function. In some cases it is achieved via 
the change of protein cellular localization. This study demonstrates that Giardia produces 
NO and nitrosylates proteins. Various techniques were used: fluorescent staining of cells, 
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the Griess assay, and the biotin-switch method. GNP and glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH) were identified as key nitrosylated proteins. Incubation of 
recombinant GNP with an NO donor affects the catalytic activity of the enzyme, 
suggesting that the enzyme’s affinity for the substrate increases upon nitrosylation. In 
vitro mutational studies identified two cysteines (position 156 and 230) within GNP as 
targeted residues. GAPDH’s activity, on the other hand, is significantly decreased during 
encystment in comparison with GAPDH from non-encysting trophozoites. Incubation of 
trophozoite lysates with NO donors also significantly decreased the enzyme activity in a 
time-dependent manner, showing that nitrosylation might be acting as an allosteric 
effector on enzymes and changing their catalytic properties and in that way, the metabolic 
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                                                 INTRODUCTION 
 
Giardia intestinalis is a protozoan parasite that colonizes the upper small intestine 
and causes one of the most widely spread water-borne infections, giardiasis. The 
World Health Organization estimates that approximately 200 million people are  
carriers may play a significant role in the spread of infection, especially among 
children. Outbreaks of giardiasis in the USA often start in daycare centers. According 
to the Environmental Protection Agency the percentage of infected children ranges 
from 7 to 54 among different populations and regions. Giardiasis causes nutrient 
malabsorption and severe dehydration, which is especially dangerous in children 
under 5 years old. Some studies indicate severe defects in the growth and 
development of the infected infants (Adam, 2001; Bope et al., 2012; Savioli et al., 
2006).  
 GIARDIASIS  
Giardiasis is initiated by ingestion of cysts through contaminated food or water 
(e.g. sewage discharge, run-off from livestock) (Fig. 2). However, a direct fecal-oral 
route often occurs among children in childcare facilities and also among homosexuals 
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(Savioli et al., 2006). Introduction of as few as 10 cysts is enough to establish an 
infection (Adam, 1991). After exposure to the acidic environment of the stomach 
cysts undergo excystation, and the released trophozoites colonize the lumen of the 
small intestine, mostly the duodenum and jejunum. As parasites travel down the 
intestine they undergo encystment, and fully formed cysts are released into the 
environment (Fig. 2). The majority of infected individuals stay asymptomatic, while 
others develop clinical symptoms in 1-3 weeks (Gardner and Hill, 2001). 
BIOLOGY OF GIARDIA 
Giardia is a binucleated, amitochondriate flagellated protozoan parasite. Although its 
exact phylogenetic position is uncertain, the small subunit RNA gene sequence analysis 
supports its early divergence in the phylogenetic tree along with Trichomonas. Giardia 
belongs to the kingdom Excavata, phylum Fornicata, order Diplomonads (Simpson et al., 
2002). According to morphological characteristics the genus Giardia is divided into three 
species: G. agilis (amphibian parasite), G. muris (parasite of rodents, birds, and reptiles), 
and G. intestinalis, which was originally identified as a human parasite (Adam, 1991). 
The precise analysis of small subunit (16S) rRNA in various isolates  showed that G. 
intestinalis, also known as G. duodenalis and G. lamblia, could be found in many wild 
and domestic mammals, excluding muskrats, voles, and some mice (van Keulen et al., 
2002). Therefore, it is more accurate to say that Giardia intestinalis exists in eight 
different genetic ―assemblages‖, ranging from A to H. Different assemblages carry 
genetically determined host specificity. For instance assemblages A and B are capable of 
causing infection in humans. Some of these assemblages may be transmitted from 
animals to humans and vice versa (H. van Keulen et al., 2002; Cotton et al., 2011).  
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Giardia has a simple life cycle, consisting of two forms: a trophozoite (trophic 














Figure 1. Giardia intestinalis: scanning electron micrographs (panels A-C) and 
diagram of microtubular cytoskeleton (panel D). 
(A) Giardia trophozoite; (B) Giardia trophozoites colonizing intestinal villi, (C) in vivo 
derived cyst at CSU. Taken from Erlandsen et al. (1996).  
(D) Diagram of a Giardia trophozoite’s: microtubular skeleton of the trophozoite is 
characterized by four pairs of flagella (anterior (afl), caudal (c), posterior (pfl), ventral 
(vfl)), the ventral disc (vd), the funis (fn) and the median body (mb). Nuclei are labeled 
(N). The spatial position is demonstrated by the following planes: left-right (L-R), dorsal-











The trophozoite is a pear-shaped motile form of approximately 6 by 10 µm with four 
pairs of flagella and two nuclei (both are transcriptionally active). The cytoskeleton is 
extensive and includes a body, the median body, and a ventral disk on the anterior two-
third of the ventral surface (Fig. 1, D). Giardia trophozoites persist in the host small 
intestine attached to the epithelium (Fig. 1, B) using suction power of the ventral disk 
(Adam, 1991; Lujan et al., 1997). The median body serves as the major morphological 
distinguishing structure among Giardia species due to high variability in its shape, 
number and position, however, its exact function is not known (Piva and Benchimol, 
2004). There are no mitochondria or Golgi apparatus in trophozoites (Adam, 1991).  
The cyst is resistant to the external environment and gastric acid and is 
approximately 5 by 8 µm (Adam, 1991). It is protected by the cyst wall, which consists of 
two layers: an outer filamentous layer (7 - 15 nm in width) consisting of galactosamine, 
most likely in the form of N-acetylgalactosamine, and polypeptides, and an inner double 
membrane layer (Jarroll et al., 1989; Jarroll et al., 1995, Manning et al., 1992; Gerwig et 
al., 2002). Although Giardia lacks true mitochondria, both trophozoites and cysts contain 
mitosomes: mitochondria highly reduced in structure and function, found in some 
unicellular eukaryotes, and lysosomes or lysosome-like vacuoles, enriched in cysteine 
proteases (Lindmark, 1988; Adam, 1991; Dolezal et al., 2005). 
 The goal of the current project is to investigate the regulation of the encystment 
mechanism with focus on the primary enzymes initiating cyst wall formation. 
Understanding encystment regulation will allow us to identify the major control points of 
this process and identify new and powerful therapeutic targets. The working hypothesis is 





Figure 2. Diagram of the Giardia life cycle. 
 
Clinical signs of infection may include but are not limited to, nausea, vomiting, 
weight loss, bloating, abdominal pain, and diarrhea (Langford et al., 2002; Cotton et al., 
2011). Increasing evidence has also implicated Giardia pathogenesis in the development 
of chronic gastrointestinal disorders including Irritable Bowel Syndrome (IBS) (Cotton et 
al., 2011). Tight attachment between Giardia trophozoites and intestinal epithelial cells 
triggers a series of events that culminate in the production of diarrhea (Cotton et al., 
2011). Giardia induces a caspase-dependant apoptosis of intestinal epithelium, a 
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reduction in total intestinal absorptive surface area, and a shortening of epithelial brush 
border microvilli. The shortening of the microvilli results in nutrient and electrolyte 
malabsorption, anion hypersecretion and increased intestinal secretion. The osmotic 
gradient, created due to the above mentioned conditions, draws water into the lumen of 
the small intestines (Cotton et al., 2011). Although giardiasis is a non-invasive infection, 
the intestinal permeability is increased as a result of apoptosis (Langford et al., 2002; 
Cotton et al., 2011).   
B lymphocytes and IgA play a central role in clearance of the infection, but most 
probably not by direct killing but rather by detachment of the parasite (Langford et al., 
2002). At the same time the exposure to the host epithelial cells results in the induced 
expression of certain Giardia genes involved in the evasion of the host’s humoral 
immune response. The main proteins that are involved in this mechanism are variant 
surface proteins (VSP), only one of which is expressed at a time, surface lectins, and 
cysteine proteases that cleave human IgA (Cotton et al., 2011). The other mechanism is 
by the consumption of exogenous arginine, a key metabolite required for production of 
epithelial nitric oxide which is giardiastatic (Cotton et al., 2011). Giardia also releases an 
―enterotoxin‖ that causes excessive ion secretion and intestinal fluid accumulation and 
other unknown products that modulate the behavior of dendritic cells (Cotton et al., 
2011). 
Giardiasis is diagnosed using IFA, ELISA, and PCR, however stool sample 




Among the drugs used to treat giardiasis are nitroimidazoles, quinacrine, 
furazolidone, benzimidazoles, and paromomycin (Gardner and Hill, 2001). 
Metronidazole and tinidazole are the only nitroimidazole drugs available for treatment in 
the USA, and the most commonly used worldwide (Gardner and Hill, 2001). After 
entering the trophozoite the drug is activated and covalently binds DNA causing its 
damage (Gardner and Hill, 2001). Metronidazole completely inhibits the trophozoite’s 
oxygen uptake and motility resulting in cell death; however, it has no effect on the cyst’s 
oxygen uptake or their ability to excyst in patients (Jarroll and Lindmark, 1990). This 
leads to the excretion of high numbers of viable cysts by those treated individuals. 
Metronizazole also has side effects such as headache, vertigo, nausea, and metallic taste 
in the mouth (Gardner and Hill, 2001). The drug can be carcinogenic in mice and rats at 
high doses over a long period of administration (Gardner and Hill, 2001). Tinidazole, on 
the other hand, is effective at a single dose and is well tolerated (Adam, 1991). 
Quinacrine, despite its effectiveness against giardiasis, causes severe side effects, such as 
toxic psychosis (Adam, 1991; Gardner and Hill, 2001). A number of other drugs such as 
paromomycin, azithromycine, and rifampin were successfully applied in vitro; however, 
they have not been tested extensively in clinical settings (Adam, 1991; Gardner and Hill, 
2001). 
METABOLISM 
Giardia is classified as an aerotolerant anaerobe. The parasite catabolizes glucose 
through the Embden-Meyerhof-Parnas and pentose phosphate pathways. The pyruvate 
produced in glycolysis is incompletely oxidized to CO2, acetate, ethanol, and alanine. 
Depending on oxygen availability the ratio of acetate/ethanol varies. Acetate dominates 
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under aerobic conditions, while ethanol is the main anaerobically produced product 
(Jarroll and Lindmark, 1990). The energy is generated by substrate level phosphorylation. 
ATP can also be produced from arginine via the arginine dihydrolase pathway (ADHP) 
(Schofield et al., 1990). Giardia obtains arginine from the host in exchange of ornithine 
and converts it to citrulline, which is converted to ornithine and carbamoyl-P (Knodler et 
al., 1995). Carbamoyl-P is subsequently converted to CO2 and NH4
+
 releasing ATP (Fig. 
3). 
 
           
Figure 3. Arginine dihydrolase pathway.  
The enzymes are labeled as follows: 1. Arginine deiminase (ADI); 2. Ornithine 
transcarbamoylase (OTC), 3. Carbamate kinase (CK). Taken from Adam (2001). 
 
In the presence of oxygen trophozoites respire by a flavin-iron sulfur protein-
mediated electron transport system. In 1989, Paget et al. demonstrated that G. muris cysts 
respire oxygen at approximately 10 - 20% of the trophozoite’s rate. Giardia relies on 
salvage rather than de novo synthesis of lipids, purines, and pyrimidines (Aldritt et al., 
1985; Jarroll et al., 1981; Jarroll and Lindmark, 1990; Kulda and Nohýnková 1995; Wang 




triacylglycerides, and phospholipids Giardia seems to obtain from serum in in vitro 
experiments and bile from its host (Jarroll and Lindmark, 1990; Luján et al., 1996). 
However, Gillin et al. (1986) showed that G. intestinalis can grow in serum-free medium, 
containing cholesterol and six bile salts instead. 
ENCYSTMENT 
The conditions that trigger the encystment process in trophozoites remain unknown. 
Some authors believe that it is bile, or more precisely bile salts and a shift in pH that 
causes encystment (Gillin et al., 1987; Gillin et al., 1989; Schupp et al., 1988; Kane et al., 
1991). However, Sterling et al. (1988) demonstrated that trophozoites undergo 
encystment even under bile starvation conditions. In 1996 Luján et al. demonstrated that 
the encystment process is controlled by cholesterol availability. Analyzing different 
regions of infected human and several animal intestines Luján et al. (1997) showed that 
nonencysting parasites concentrate in the jejunum where lipid absorption takes place. 
This, along with the parasite’s dependence on host lipids, pointed to cholesterol 
starvation as the main encystment triggering factor. Moreover, it was shown that trace 
amounts of salts solubilize lipids making them more available for the cell, while a high 
concentration inhibits cholesterol uptake (Farthing et al., 1985). The mechanism of 
sensing low cholesterol levels and passing the signal to the parasite nucleus remains 
unclear.  
During encystment, trophozoites express cyst antigens after 6 h and develop Golgi-
like components or encystment specific vesicles (ESV) (Fig. 4) after 6 - 18 h (Reiner, 
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Douglas and Gillin, 1989; Adam, 1991; Faubert, Reiner, and Gillin, 1991; Luján et al., 





Figure 4. Encystment specific vesicles (ESV) in the encysting Giardia.  
(A) Indirect immunofluorescence microscopy. ESVs are labeled with rabbit cyst-specific 
serum and goat anti-rabbit IgG-FITC. Courtesy of Drs. J. Shields and H. van Keulen.    
(B) Transmission electron micrograph. ESVs are indicated with arrows. Taken from 
Erlandsen et al. (1996). 
 
Among cyst-specific protein are three proteins rich in leucine which are delivered to 
the cyst wall via ESVs (cyst wall protein; CWP 1 - 3) (Luján et al., 1995; Mowatt et al., 
1995; Sun et al., 2003). Giardia’s ability to use exogenous glucose is lost 10 h post-
induction (Jarroll et al., 2001). Approximately at the same time the initiation of cyst wall 
fibril assembly was shown by Chavez-Munglia et al. (2007) using ruthenium red staining. 
The cyst wall is assembled from separate fibrils organized in bundles which grow and 
overlap forming a mesh like structure. The highest growth rate is observed between 30 - 
50 h of encystment and ceases by 65 h (Erlandsen et al., 1989; Luján et al., 1995; 
Arguello-Garcia et al., 2002).  
Experiments by Su et al. (2007) showed that neomycin and puromycin selectively 
affected Giardia gene expression. Among genes that were affected are enzymes involved 
 






in glycolysis and ADHP (GAPDH, ornithine transcarbamoylase, carbamate kinase), as 
well as CWP 1 - 3. These observations point to the existence of a common signaling 
pathway that connects the encystment, glycolysis and ADHP.  The other possible 
candidates for participation in the signaling pathway are protein kinase C (PKC) and 
PKA. PKC inhibitors block encystment in a dose-dependent manner, and PKA was 
stimulated by intracellular cAMP during encystment (Bazan-Tejeda et al., 2007).   
MOLECULAR BIOLOGY 
Giardia is a polyploid organism. Its ploidy and the chromosome numbers vary, 
depending on the strain from 4N to 12N and from 5 to 8 (Adam, 2001). Trophozoites 
divide by binary cell fission, the molecular mechanism of which is not known (Adam, 
1991). Giardia has a very compact genome with genes arranged in a single transcription 
unit; introns are rare (so far reported in only three genes) (Vanacova et al., 2003; Jeffares, 
2006; Roy and Gilbert, 2006). The promoter elements of Giardia are short, AT-rich and 
located within 70 - 150 bp upstream of the transcription start site. Beside the core 
promoter element Giardia also has multiple initiator sequences that are able to drive 
transcription independently, producing high numbers of sterile transcripts (Vanacova et 
al., 2003). Giardia mRNA possesses unusually short 5’ and 3’ untranslated regions. 
Differential gene expression was recorded during encystment and excystation. The 
Giardia genome encodes a Myb-like transcription factor, and Myb-binding sequences 
were identified in at least 5 genes induced upon encystment: cyst wall proteins 1 - 3, 
glucosamine 6-phosphate deaminase (GNP), and the Myb-like gene itself (Sun et al., 
2002).    
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When the Giardia genome is compared to the human genome, it is especially 
striking that Giardia has a high gene density and that the distance between genes is very 
small (Manning et al., 2011; Venter et al., 2001). Some other differences are shown in 
Table 1. 
Table 1. Comparison of the Giardia genome with the human genome. Based on data 
presented by Manning et al. (2011) and Venter et al. (2001). 
 Giardia Human  
Genome size in basepairs 11.7 x 10
6
 2.66 x 10
9
 
G + C content 49 % 38 % 
Annotated genes 6,470 26,383 
Average gene size (bp) 1,283 27,000 
Hypothetical genes ND* 12,731 
Intergenic distance (bp) 372 ND* 
Gene density 0.58/kbp 0.005 - 0.023/kbp 
Number of protein kinases 80 868 
*ND - not determined 
 
POST-TRANSLATIONAL PROTEIN MODIFICATION AND ITS EFFECT 
ON THEIR ACTIVITY 
Reversible post-translational modifications are widely used to regulate protein 
activity (Gill, 2004). They provide a cell with a fast and effective mechanism of 
accommodation to changing environmental conditions. The use of multiprotein 
complexes and reversible protein binding and modification appears to be a universal 
process in cells. It allows for quick changes in biological regulation using fast on and off 
switching of processes, and adds a whole new dimension to the control of gene 
expression. However, the variety of modifications is extremely large and complex. 
Proteins can be modified by attachment of small chemical groups, such as methylation, 
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acetylation, glutathionylation, nitrosylation, phosphorylation, to mention just a few, or 
attachment of larger molecules such as sugars, lipids, or other polypeptides, for instance, 
ubiquitin.   
NITROSYLATION 
Nitric oxide (NO) is a small highly diffusible molecule that is widely distributed in 
nature. Intracellularly it is produced by an enzyme nitric oxide synthase (NOS), which 
converts the amino acid arginine into citrulline with the release of NO. Depending on the 
cell’s nature there are three general types of NOS: neuronal, epithelial, and inducible 
(specific for macrophages). NO was originally discovered in mammals as one of the 
endothelial-derived blood vessels’ relaxing factors and a macrophage-derived molecule 
that mediates killing of tumor and bacterial cells (Gaston et al., 2003; Hara and Snyder, 
2006; Ischiropoulos, 2005). Since then, many other functions have been attributed to NO. 
Some of them are inhibition of platelet aggregation and leukocyte adherence, ion-channel 
activity and mitochondrial function, immune response modulation and killing of 
microbial agents, apoptosis and tissue-damaging in autoimmune diseases (Hernández-
Campos et al., 2003). NO is also produced by some invertebrates (insects and mollusks), 
nematodes (Ascaris suum, Dirofilaria immitis, and Brugia sp.), plants, prokaryotes, and 
protozoa (Hernández-Campos et al., 2003). In prokaryotes, NO serves as an endogenous 
regulator of gene expression and also is an intermediate of denitrification processes 
(Cutruzzola, 1999; Spiro, 2006; Zumft, 2002). NO-producing ability of protozoa as well 
as the function of the molecule is not well studied.  
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NO reacts with cysteine residues in proteins, causing S-nitrosothiol formation. This 
post-translational modification plays a major role in intra-, as well as, inter-cellular 
signaling (Gaston et al., 2003). The chemical term used for this process is nitrosation; 
however, in the literature this protein modification is commonly called nitrosylation. 
Some authors have used the consensus motif [G/S/T/C/Y/N/Q] [K/R/H/D/E] C [D, E] to 
predict protein nitrosylation. The amino acids arginine (R) and aspartate (D) that flank 
cysteine in the motif make NO more electrophylic, serving as the partial electron acceptor 
(Stamler et al., 1997; Gaston et al., 2003). At the same time others suggest that 
nitrosylation is rather commanded by the cysteine environment, provided by a protein’s 
tertiary structure (Marino and Gladyshev, 2009). There are two well-recognized 
nitrosylation targets: soluble guanylate cyclase and the cytochrome oxidase of complex 4 
in the mitochondrial electron transport chain (Morton and Vermehen, 2007). In many 
biological systems transferring of NO
+
 to a sulfhydryl group affects protein localization 
and function or affects gene expression (Mohr et al., 1999). Here are just a few presently 
know targets of so called S-nitrosylation: bovine serum albumin, tissue-type plasminogen 
activator, GAPDH, oncogenic p21
ras
, and some transcription activators (Mohr et al., 
1999). Nitrosylation could inactivate as well as activate protein catalytic activities. A 
good example of this is glutathione S-transferase. The microsomal enzyme is two-fold 
upregulated following nitrosylation, while the cytosolic one is downregulated (Ji et al., 
2002). Recently NO production has been detected in Trichomonas vaginalis and G. 
intestinalis (Harris et al., 2006); NOS activity was measured using radioactively labeled 
arginine. Confocal microscopy using the fluorescent indicator specific for oxidized NO 
showed population heterogeneity, suggesting a cell cycle dependence of NO. A Giardia 
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database (McArthur et al., 2000) search resulted in finding a gene annotated as inducible 
NOS (iNOS). Typical NOS is composed of two domains: an oxygenase and a reductase. 
The former serves for binding the substrate and biopterin (Mitchell et al., 2007). The 
Giardia enzyme clearly misses the oxygenase domain, however, it has a reductase-like 
domain. Therefore, it cannot be a typical NOS.   
UBIQUINATON 
Ubiquination is a reversible post-translational modification of cellular proteins. It is 
present in eukaryotes and archaebacteria, but absent from eubacteria (Krebber et al., 
1994). Originally discovered as a mediator for protein proteasomal or lysosomal 
degradation, later involved into the regulation of the cell cycle, protein trafficking, DNA 
repair, apoptosis, and signal transduction (Kimura and Tanaka, 2010; Claugue and Urbé, 
2006).  Ubiquitin (Ub) is a highly conserved 76 amino acid protein that can form an iso-
peptide bond between its carboxy-terminal glycine and the ε-amino group of lysine 
residues in a target protein (Kimura and Tanaka, 2010). The mammalian genome has four 
Ub genes: two code for poly-Ub, while the other two code for fusions with ribosomal 
proteins. Yeasts have a single poly-Ub gene and three ribosome fusion genes. Knocking 
out Ub-encoding genes results in vulnerability to stresses in yeasts as well as infertility, 
neurodegeneration and embryonic lethality in mice (Kimura and Tanaka, 2010).  
Protein ubiquination is catalyzed by the well-coordinated action of three enzymes: an 
Ub-activating enzyme (E1), an Ub-conjugating enzyme (E2), and an Ub ligase (E3). Each 
one is highly specific for its substrate (Kimura and Tanaka, 2010). Ub itself possesses 
seven internal lysines making formation of a poly-Ub chain possible. As a result, 
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cytosolic Ub can be found as a monomer, substrate-conjugated mono- or poly-Ub, or an 
unanchored Ub chain (Kimura and Tanaka, 2010). The common sites for Ub 
polymerization are lysine 48 and 63 (Gill, 2004). In order to interact with a proteasome, 
the Ub chain has to be at least four subunits long and is usually attached through lysine 
48, however, mono-ubiquination is sufficient for degradation of one of the transcription 
factors from the nuclear factor-κB family (Ciechanover, 1998; Claugue and Urbé, 2006; 
Gill, 2004; Kravtsova-Ivantsiv et al., 2009). Targeting to the lysosome on the other hand, 
as was shown in yeast, requires at least two Ub molecules linked through lysine 63, 
however, there are exceptions (Claugue and Urbé, 2006). Protein modifications via Ub 
attachment are usually predetermined by either phosphorylation or by internal small N-
terminal motifs, such as a D-box, or a KEN box. The D-box is a consensus sequence of 
R-A/T-A-L-G-X-I/V-G/T-N, while the KEN box is K-E-N-X-X-X-N, where X stands for 
any amino acid (Jadhav and Wooten, 2009). Ubiquination could be reversed by Ub-
specific proteases called deubiquitinating enzymes (Dubs). These enzymes are also 
involved in the processing of Ub precursor’s terminal domain (carrying an R-G-G 
sequence) to reveal C-terminal glycine (Ciechanover, 1998). It is estimated that 
mammalian cells possess approximately 600 E3s and 100 Dubs (Kimura and Tanaka, 
2010). The pool of cellular Ub is maintained at a certain level through transcriptional 
regulation, and a coordinated work of E3 ligases, 26S proteasome, and Dubs 
(Ciechanover, 1998; Kimura and Tanaka, 2010).  
While polyubiquination in general targets proteins for degradation, single Ub 
attachment regulates membrane protein trafficking, transcription factor activity, 
subcellular localization, protein-protein interactions, and endocytosis (Claugue and Urbé, 
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2006; Gill, 2004; Kravtsova-Ivantsiv et al., 2009; Schnell and Hicke, 2003). Mono-
ubiquination serves as a sufficient signal for cell surface protein internalization and a 
sorting signal for transmembrane and biosynthetic proteins in yeasts and mammals 
(Schnell and Hicke, 2003). Histones H2B, H2A, H1 and H3 were modified by a single 
Ub or a short chain. In yeast, H2B ubiquination is required for meiosis and influences 
silencing at the telomere. H2B ubiquination is also required for methylation of H3 at 
multiple sites (Gill, 2004; Schnell and Hicke, 2003). Several Ub-binding domains (UBD) 
interacting with two hydrophobic patches on the Ub surface have been characterized 
(Gill, 2004; Schnell and Hicke, 2003). Among them are Ub-associated domain, UB-
interacting motif, and Ub E2 variant (Gill, 2004). A number of cellular proteins, such as 
the above mentioned proteins are involved in endocytosis or sorting and the budding 
machinery carry one of the UBDs. These proteins can bind mono- or poly-Ub, otherwise 
recruit E2 and E3 and promote mono-ubiquination (Schnell and Hicke, 2003). Schnell 
and Hicke (2003) suggested that Ub-binding proteins protect a mono-ubiquitinated 
partner from poly-Ub chain formation.  
A number of Ub-related proteins have been identified in different organisms. Among 
them are yeast RUB 1, Parkin, and a group of small Ub-related modifier (SUMO) in 
mammals. Parkin is implicated in the pathogenesis of certain forms of Parkinson, while 
SUMO (exactly SUMO1) is primarily known for its targeting of RanGAP1 (nuclear 
transport protein) to the nuclear pore (Ciechanover, 1998). SUMO has about 20% overall 
similarity with Ub, however, it has a different distribution of the charged residues and a 
15 amino acids N-terminal extension (Gill, 2004; Jadhav and Wooten, 2009). Only one 
SUMO protein was reported in yeasts (Wilkinson and Henley, 2010). Mammals have 
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four different SUMO isoforms (SUMO 1-4), however, SUMO 1 is the most commonly 
found one (Jadhav and Wooten, 2009). Unlike ubiquitin SUMO in general functions as a 
monomer (Gill, 2004). The process of SUMOylation is similar, though much simpler 
compared to ubiquination (Gill, 2004; Yeh, 2009). It usually targets lysine in the 
consensus sequence Ψ-K-X-E (where Ψ represents large hydrophobic amino acids, while 
X stands for any amino acid) (Jadhav and Wooten, 2009). In some cases, SUMOylation 
depends on previous phosphorylation of a target protein (similar to Ub), an example of 
that is heat shock protein 1 (Andreou and Tavernakaris, 2009). In order to be linked to a 
lysine SUMO has to be activated by proteolytic cleavage. The cleavage reveals two 
terminal glycine residues and is performed by sentrin/SUMO-specific proteases (SENP). 
The same SENP (two identified in yeast and six in humans) are responsible for 
deconjugation of SUMO. The rest of the SUMOylation machinery engages a single 
conjugating enzyme, and a limited number of ligases (Wilkinson and Henley, 2010; Yeh, 
2009). Coordination of SUMO attachment and deconjugation is achieved through 
transcriptional regulation of SENP as well as their import/export between nucleus and 
cytosol (Yeh, 2009). SUMOylation usually results in alteration of target protein 
localization, activity, or interaction with binding partners. It is rarely associated with 
protein degradation (Andreou and Tavernakaris, 2009). SUMOylation could also protect 
proteins from degradation through the ubiquitin-proteasomal pathway (Andreou and 
Tavernakaris, 2009). Unlike ubiquination SUMOylation is hard to detect as only about 
1% of total cellular proteins are modified (Wilkinson and Henley, 2010). Most of the 
known SUMO-modified targets are nuclear proteins as SUMOylation is frequently 
associated with transcriptional regulation (Andreou and Tavernakaris, 2009; Gill, 2004). 
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If ubiquination of transcriptional factors and histones in general results in increased gene 
expression, SUMOylation is associated with decreased gene expression. It is achieved 
through either binding to transcriptional (co)repressors or promotion of interactions with 
proteins that repress transcription (Gill, 2004). At the same time SUMOylated proteins 
are involved in genome integrity, DNA repair, apoptosis, signal transduction and 
mitochondrial fission (Andreou and Tavernakaris, 2009; Gill, 2004; Scorrano and Liu, 
2009). It seems like modifications via attachment of SUMO and Ub are antagonistic, as 
they often target the same lysine residue, however, they do not compete directly (Gill, 
2004; Wilkinson and Henley, 2010). SUMO also competes with acetylation of the same 
lysine (Wilkinson and Henley, 2010). Among proteins targeted by SUMOylation are: 
nuclear pore complexes RanGAP1, chromatin structure regulating histone H4, 
transcriptional co-activators HDAC1 and 4, transcriptional factors involved in cytokine 
activity, tumor growth and other signal transduction pathways (p53, cIRF-1, Myb, 
Smad4)  (Gill, 2004). An example of regulation of subcellular localization is RanGAP. 
Non-modified protein is typically found in the cytosol, whereas the SUMOylated one is 
associated with a nuclear pore (Gill, 2004). A number of proteins are associated with 
SUMO and a conserved SUMO-interacting motif (SIM) has been identified (Andreou 
and Tavernakaris, 2009; Gill, 2004; Wilkinson and Henley, 2010). Among the proteins 
associated are histone deacetylases 2 and 6 (HDAC2 and HDAC6) (Andreou and 
Tavernakaris, 2009). A cellular SUMOylation system is also exploited by several 
bacterial and viral pathogens to establish an infection.  It was shown that Yersinia pestis 
(bacteria causing the black plaque), encodes SUMO protease, whose activity is important 
for suppression of the host immune system (Gill, 2004).  
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The ubiquitin protein as well as ubiquination and deubiquination are conserved 
across eukaryotes (Ponder and Bogyo, 2007). Both the number of Ub molecules and 
location of the modification are responsible for the following protein destiny. 
Considering their complex life cycle, various mechanisms of host immune system 
evasion, and establishment of an infection, parasites should possess a well regulated 
system of protein expression–degradation. However, protein modification by means of 
ubiquination is not very well studied in protozoa. Ub-like modifiers, including SUMO 
and their deconjugating enzymes were identified in Plasmodium, Toxoplasma, 
Leishmania, Trypanosoma, Entamoeba, Giardia, Cryptosporidium, and Theileria spp. 
(Ponder and Bogyo, 2007). 
The presence of a single Ub gene in Giardia was reported first by Krebber et al. in 
1994. Since then the entire ubiquination-dependent protein degradation machinery, 
including two E1, six E2, three E3, four deubiquitinating enzymes, as well as a 20S 
proteasome were identified in Giardia (Emmerlich et al., 1999; Gallego et al., 2007). In 
addition a Ub-ribosomal fusion gene was described (Gallego et al., 2007). Further 
analysis showed that one out of two E1 enzymes was likely a SUMO protein activating 
enzyme (Gallego et al., 2007). Isolated Giardia 20S proteasome complexes resembled the 
higher eukaryote proteasome; however, it was not active possibly due to damage during 
the process of purification (Emmerlich et al., 1999; Emmerlich et al., 2001; Paugam et 
al., 2003). Transcriptional studies (Gallego et al., 2007) did not detect a difference in Ub 
level between trophozoites, encysting cells and those undergoing excystation. At the 
same time this group registered a significant increase in SUMO-activating E1 and a 
significant decrease in E3 ligase transcript level after 6 h of encystment. A different 
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group, however, showed an increased expression of the Ub gene (Gen Bank # 70050) 
along with GNP1 and cyst wall protein 2 (CWP2) during encystment (Eligio-Garcia et 
al., 2011). However, close scrutiny of this manuscript revealed that GNP2 not GNP1 was 
analyzed and that not ubiquitin itself but an ubiquitin carboxyterminal hydrolase (EC 
3.1.2.15, ORF 102710 in the Giardia Database) was upregulated at the transcription 
level. Therefore nothing is yet known with certainty about transcriptional control of Ub in 
Giardia.  
The processes of encystment and excystation involve differential gene expression 
and quick and specific protein turnover, which may be indicated by the presence of the 
Ub/proteasome system. Some researchers reported persistent Ub expression during the 
parasite’s differentiation processes, whereas, variation in transcription was observed in 
activating (E1), conjugating (E2), and ligating (E3) enzymes (Touz et al., 2002).   
In summary there is experimental evidence that F6P serves as a substrate for the 
energy production and cyst wall synthesis. There is also experimental evidence that G. 
intestinalis produces NO, the molecule that operates as a cell cycle regulator in many 
systems. The primary questions addressed in this dissertation are: 
1. Is there nitrosylation in G. intestinalis?  
2. What enzymes involved in the energy production and cyst wall synthesis are 
nitrosylated? What is the effect of enzyme nitrosylation? 










MATERIALS AND METHODS 
 
Chemicals that were used in the experiments were supplied by Sigma Aldrich (St. 
Louis, MO) or Fisher Scientific (Pittsburg, PA) unless otherwise indicated. 
Cell culture and encystment – G. intestinalis trophozoites (Assemblage A, strain 
MR4) were grown axenically at 37 
oC in Diamond’s TYI-S-33 medium, containing 1 
mg/ml bovine bile, with the pH adjusted to 7.0 (Lopez et al., 2003). For encystment, the 
growth medium was replaced with TYI-S-33 medium with 10 mg/ml bovine bile, 
adjusted to pH 7.6. Encystment is asynchronous and normally 70–80% of the 
trophozoites completely transform into cysts within 48 – 72 h. The process of encystment 
was monitored using light microscopy and cysts were identified on the basis of shape and 
water resistance. Encystment was determined from the number of cysts formed and is 
presented as a percentage of the total cell number. 
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Protein concentration — Protein concentration was measured using the Bio-Rad 
(Bio-Rad, Hercules, CA) method with Bovine Serum Albumin (BSA) as standard or 
using Bradford reagent (Amresco, Solon, OH).  
SDS-Polyacrylamide gel (SDS-PAG) electrophoresis — PAG electrophoresis was 
done according to the method of Laemmli (Laemmli, 1970) with modifications. Protein 
samples were loaded onto 15.8% SDS-PAGs and electrophoresed in buffer (25 mM Tris-
HCL, 250 mM glycine, 0.1% SDS, pH 8.3). Between 10 - 15 µg of total protein were 
usually loaded per well. In Western Blot analysis of GNP from trophozoites and cells 
induced to encyst for various lengths of time, protein samples were separated using 
Novex® 4-20 % Tris-Glycine Midi gels (Life technologies, Grand Island, NY).  
Western Blot analysis — SDS-PAGs were transferred routinely to Immobilon 
Polyvinylidene Fluoride (PVDF) membranes (Fisher Scientific) for 1 h at 1 mA/ cm
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using a semi-dry transblotter according to the manufacturer’s specifications (Fisher 
Scientific). After blotting, the membranes were blocked with 5 % non-fat dry milk 
dissolved in 20 mM Tris-HCl, pH 7.6, 150 mM NaCl (TBS) plus 0.1 % Triton X-100 
(TBS-T) overnight at 4˚C. Blots were routinely incubated with primary antibodies at 
appropriate dilution for 2 h at room temperature with agitation. Afterwards the blots were 
washed thoroughly with TBS with 0.05% Triton X-100 for 1 h at room temperature with 
agitation. Washes were changed every 15 min. Secondary goat anti-rabbit antibodies 
conjugated to horseradish peroxidase (HRP) (Santa Cruz Biotechnology, Santa Cruz, CA) 
were used at 1:10,000 dilution. The blots were incubated with secondary antibodies for 1 
h at room temperature with agitation. The blots were washed as described previously. 
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The final wash was performed with TBS only. Blots were developed using Pierce ECL 
Western Blotting Substrate (Fisher Scientific).  
 Detection of Nitric oxide – NO production by encysting and non-encysting Giardia 
trophozoites was estimated spectrophotometrically as formed nitrite (NO2
-
) using the 
Griess Reagent System (1% sulfanilamide in 0.1 M HCl and 0.1% N-(1-naphthyl) 
ethylenediamine dihydrochloride (NED) (Promega Corporation). Briefly, 50 µl of 
cellular lysates were incubated with 50 µl of sulfanilamide solution for 5 min protected 
from light. Following that 50 µl of NED were added to the mixture and incubated for 
another 5 min. The absorbance of the formed azocompound was measured with a Perkin 
Elmer 1420 Multilabel Counter microtiter plate reader with a 570 nm filter for 1 sec (see 
Chapter III for the details).   
Nitric Oxide Donor – Nitrosocysteine (cys-NO) was synthesized using the protocol 
of Martínez-Ruiz and Lamas (2007). The concentration was measured using a Beckman 





diluted as indicated. Various concentrations ranging from 2 µM to 1 mM were used for 
the incubation with cells, cellular protein lysates, and recombinant protein.   
Indirect immunofluorescence –Trophozoites and cells induced to encyst for different 
times were harvested and washed. Indirect immunofluorescence was performed 
according to the procedure of Repasky et al. (1982) with modifications. Washed cells 
were diluted until slightly turbid in 3 % Formalin-PBS. The Micro slides (Corning 
Incorporated, Corning, NY) were coated with 0.01% poly-L-lysine, allowed to sit for 10 
min, and washed with Phosphate - buffered saline (PBS). Cells in formalin-PBS solution 
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were transferred to the treated slide and incubated for 20 min at room temperature. The 
adherent cells were washed in PBS with 2% Triton X-100 and blocked with calf serum 
for 15 min at room temperature. Following that slides were washed twice in PBS-Triton 
X-100 and incubated with 20 - 30 µl of primary antibodies at appropriate dilution for 1 h 
at 37 ˚C in a wet chamber. The slides were washed twice in PBS-Triton X-100 solution 
and twice in PBS. The incubations with the secondary antibodies were also performed for 
1 h at 37 ˚C in a moist chamber. For better contact incubation was performed under a 
cover glass that was later removed. After secondary antibody treatment, slides were 
washed three times with PBS-Triton X-100 solution, once with PBS, and once with 
distilled water. The 0.17 mm cover glass (Corning) were mounted on to the slides using 
Vectashield®Hard Set Mounting Medium with DAPI (Vector laboratories, Burlingame, 
CA). The slides were sealed using nail polish and dried in the dark. Cells were observed 
with a Zeiss Pascal confocal microscope through a Plan-Apochromat 63 x 1.4 N.A. water 
immersion objective. For details see Chapter III and IV. 
Measurements of GNP Activity — GNP enzyme activity was determined in the 
aminating direction in a final volume 50 µl with 0.016 M of F6P as substrate. Reactions 
were carried out at 37 
o
C for 30 min, unless otherwise specified. The p-dimethylamino-
benzaldehyde (DMAB) colorimetric method was used for assays (Lopez et al., 2002). 
Reactions were terminated by heating at 100 
o
C, which was followed by a colorimetric 
reaction read at 585 nm. Each assay was performed in duplicate and repeated three or 









POST-TRANSLATIONAL MODIFICATION OF GNP AND ITS EFFECT ON 
THE ENZYME’S CATALYTIC PROPERTIES 
INTRODUCTION 
 
The enzyme glucosamine 6-phosphate isomerase (GNP) is the first enzyme in the 
encystment pathway (Fig. 5). It has been identified in several animal, fungal, as well as 
bacterial species and purified from Escherichia coli, Bacillus subtilis, Candida albicans 
and dog kidney (Fontes et al., 1995; Bustos-Jaimes and Calcagno, 2001). In E. coli, GNP 
as well as glucosamine 6-phosphate synthase (GlcN6P synthase) participate in 
aminosugar metabolism. GlcN6P synthase is responsible for D-glucosamine 6-phosphate 
(GlcN6P) production, while GNP catalyzes the reversible isomerization and subsequent 
deamination of GlcN6P into D-fructose 6-phosphate (F6P) and ammonium ion. Due to 
this fact, the enzyme’s name was changed to GlcN6P deaminase, E.C 3.5.99.6 (Fontes et 
al., 1995). Unlike the bacterial enzyme, Giardia GNP (gGNP) catalyzes the unique 
conversion and simultaneous amination of F6P to GlcN6P (Steimle et al., 1997). Thus, 
in Giardia GNP is an anabolic (synthetic), rather than a catabolic enzyme.  
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Figure 5. The pathway of giardan synthesis.  
From Jarroll et al. (2001). 
 
The same GNP aminating activity was described for some other eukaryotes and an E. 
coli K-12 mutant lacking GlcN6P synthase (Steimle et al., 1997). However, this is not the 
only difference between the E. coli and Giardia enzymes.  
GNP of E. coli (EcoGNP) is an allosterically controlled hexamer with a native 
molecular mass of 178 kDa, while gGNP is a monomer of ca. 29 kDa (Steimle et al., 
1997; Altamirano et al., 1993). EcoGNP is composed of identical polypeptide chains of 
266 residues with one catalytic (amino acids 141-148) site and one allosteric (amino 
acids 151-161) site. Amino acid residues 163-183 form the active site lid (Cisneros et al., 
2004; Horjales et al., 1999) and enclose the active site. The active site and the lid 
sequence are highly conserved among the organisms, especially in amino acids critical 
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for catalysis; these are: D 72, H 141, E 148, and R 172 (Fig. 6) (Cisneros et al., 2004, 
Horjales et al., 1999). Each E. coli monomer has four cysteine residues at positions 118, 
219, 228, and 239. The disulfide bond at C 219 along with hydrogen bonds at the C-end 
and van der Waals contacts are responsible for the monomer’s interaction (Altamirano et 
al., 1993; Oliva et al., 1995). On the other hand, C 118 and C 239, located in the area 
with high flexibility scores (as predicted by crystallography), are important for enzyme 
catalytic activity (as shown by mutational studies). Residues C 219 and C 228 are 
predicted to be in a hydrophobic area and buried inside the deaminase structure. 
However, one of them, C 228 was also shown to be an important residue for full enzyme 
activity (Altamirano et al., 1992). gGNP has 13 cysteine residues that are unevenly 
spread through the molecule, with a higher concentration at the N- and C-termini. 
Residue C 118 is conserved in the Giardia and B. subtilis (position 113 in both 
organisms) enzymes (Fig. 6). The Giardia enzyme, but not the B. subtilis one, also has 
cysteines at positions 215, 219, and 230, which is close to the EcoGNP cysteine residue 
positions (Fig. 6).  
Being a monomer gGNP is more related to the B. subtilis and C. albicans (molecular 
mass ca. 27 kDa and 43 kDa, respectively) than to the E. coli enzyme (Steimle et al., 
1997). However, it has 40% identity with the enzymes from these three organisms 
(Knodler et al., 1999).  
Two-dimensional gel-electrophoresis of native gGNP revealed two isoforms with pI 






GiaGNP1 1 ---------------MPSIHVSKCADPAIKLAHRIAEVVRSKP-----NCVLGLATGSTP 40 
GiaGNP2 1 MTVCVAQAERGASELESKAMVKKSNDAALLVAHRIAEVVRSKP-----NCVLGLATGSTP 55    
BsuNAGB 1 ---------------MKVMECQTYEELSQIAARITADTIKEKP-----DAVLGLATGGTP 40   
EcoNAGB 1 ---------------MRLIPLTTAEQVGKWAARHIVNRINAFKPTADRPFVLGLPTGGTP 45                                                                                                  
                                .  : .   *:  .: :.          ****.**.**   
 
               72  
GiaGNP1 41 IPVYQELARLHREEGLDFSQVRTFNLDEYAGLPPTHDQTYRFFMEEHLFSKVNIKPENVH 100    
GiaGNP2 56 IPVYQELARLHREEGLDFSQVRTFNLDEYAGLPPTHDQSYRFFMEEHLFSKVNIKPENVH 115   
BsuNAGB 41 EGTYRQLIRLHQTENLSFQNITTVNLDEYAGLSSDDPNSYHFYMNDRFFQHIDSKPSRHF 100   
EcoNAGB 46 MTTYKALVEMHKAGQVSFKHVVTFNMDEYVGLPKEHPESYYSFMHRNFFDHVDIPAENIN 105  
             .*: * .:*:   :.*.:: *.*:***.**.  . ::*  :*. .:*.:::  ...   
 
                         113                      138  143         
GiaGNP1 101 FLNGMASDYEKECERYEQELKAIGPCDVWLLGIGHNGHIAFNEPGSPRDSRTRVVCLTQS 160   
GiaGNP1 116 FLSGLAIRAEDECIRYENALQTIGPCDVWLLGIGHNGHIAFNEPGSPRDSRTRVVCLTQS 175   
BsuNAGB 101 IPNGNADDLEAECRRYEQLVDSLGDTDIQLLGIGRNGHIGFNEPGTSFKSRTHVVTLNEQ 160   
EcoNAGB 106 LLNGNAPDIDAECRQYEEKIRSYGKIHLFMGGVGNDGHIAFNEPASSLASRTRIKTLTHD 165 
            : .* *   : ** :**: : : *  .: : *:*.:***.****.:.  ***::  *...  
                         118                      141  148 
                         
GiaGNP1 161 TIDANARFFGNDKSKVPTKALSVGIATIMESREILLLATGESKREAVTKSVKGKCETHCP 220 
GiaGNP2 176 TIDANARFFGNDKSKVPTKALSVGIATIMESREILLLATGESKCEAVTKAIVGEPTNAVP 235   
BsuNAGB 161 TRQANARYFPSIDS-VPKKALTMGIQTILSSKRILLLISGKSKAEAVRKLLEGNISEDFP 219   
EcoNAGB 166 TRVANSRFFDNDVNQVPKYALTVGVGTLLDAEEVMILVLGSQKALALQAAVEGCVNHMWT 225 
            *  **:*:* .  . **. **::*: *::.:..:::*  *..*  *:   : *      . 
                                                                  219 
 
GiaGNP1 221 ASFLHEHPHCRFYVDMDAGKVVDNTCCQATNQASCCGSTSCHAAKA 266   
GiaGNP2 236 ASLLQRHPRCCFYVDEAAGAEVAETVTE------------------ 263   
BsuNAGB 220 ASALHLHSDVTVLIDREAASLRP----------------------- 242  
EcoNAGB 226 ISCLQLHPKAIMVCDEPSTMELKVKTLRYFNELEAENIKGL----- 266   
             * *: *.   .  *  :                             
               228        239  
 
Figure 6. Alignments of GNP from Giardia (GiaGNP), B. subtilis (BsuGNP), and E. 
coli (EcoGNP). 
* conserved residues, : conserved substitution, . semi-conserved substitution. The amino 
acids critical for catalysis (as well as their numbering) are shown in red, cysteine residues 
are indicated with turquoise color, the numbering is in black.  Allosteric site and active 
site lid are labeled in yellow and green blocks. E. coli cysteine residues and critical for 
catalysis H and E are indicated with arrows, relevant Giardia residues are indicated with 
arrow heads.  
 
 




 GlcN6P produced, 




GlcN6P consumed) (Table 2 ). Although gGNP’s Km is 2.5±0.24 mM for F6P and only 








absence of allosteric regulation (due to its monomeric structure) is compensated by 
coupling GNP with GlcN6P N-acetylase activity (Jarroll et al., 2001).    
 
Table 2. Comparative properties of native and recombinant gGNPs.  
 
Enzyme* Km, mM Vmax, µmole of product. min
-1




Aminase activity   
Native enzyme 2.5±0.24 (F-6-P) 86.3±3.2 
 19±1.9 (NH4Cl)  
GNP1 3.7±0.34 204±34 
GNP2 4.6±2.0 63±22 




Native enzyme 0.38±0.16 (F-6-P) 32.8±5.3 
   
GNP1 0.31±0.15 151±20 
GNP2 0.68±0.27 63±9.1 
*The numbers for the native gGNP are from Steimle et al. (1997); those for the 
recombinant   enzymes are from Lopez et al. (2002). 
 
 Giardia has two single-copy genes coding for GNP: gnp1 and gnp2. Both of them 
are present on chromosome 3. The predicted protein sequences of both genes have 70% 
identity with high similarity in the catalytically important area and higher variations in 
the N - and C - termini (van Keulen et al., 1998; Knodler et al., 1999). Gnp1 has an open 
reading frame (ORF) of 798 bp encoding a 29,421 Da polypeptide with a calculated pI 
comparable to that determined for the purified enzyme (Steimle et al., 1997).  
Gnp2 has an ORF of 789 bp with two possible start codons 54 bp apart. Neither of 
them gives a product with molecular mass and pI comparable with that of the purified 
native enzyme. One ORF would produce a protein with 263, the other with 244 amino 
acid residues (van Keulen et al., 1998). Gnp2 appears to be derived from a recent gene 
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duplication. The closest example of a similar organization is B. subtilis, whose genome 
also encodes two monomeric glucosamine 6-phosphate isomerases sharing only 49% 
identity (Knodler et al., 1999). In contrast the E. coli genome encodes a hexameric 
(nagB) and a tetrameric (nagA) protein (Altamirano et al., 1992; Vincent et al., 2005). 
Inducible expression of gnp1 with the product detected first at 6 h after induction was 
shown using RT – PCR and Northern blot analysis (van Keulen et al., 1998; Sun et al., 
2003). Transcription of gnp2 mRNA in encysting or non-encysting cells was not 
detected, which is consistent with the sequence analysis data (van Keulen et al., 1998). 
However, in 1999 Knodler et al. demonstrated that both genes were expressed: gnp1 is 
inducible (appearing in encysting cells), while gnp2 is constitutive (expressed at a 
constant level in trophozoites and throughout encystment). The apparent contradiction 
was explained by a difference between the strains and cultivation methods used (Lopez et 
al., 2002). 
Both genes have been cloned and sequenced by van Keulen et al. (1998). The 
product of gnp1 expression has typical glucosamine 6-phosphate isomerase activity. 
Monospecific polyclonal antibodies produced against expressed GNP1 recognized the 
purified gGNP (van Keulen et al., 1998). Western blot analysis with these antibodies 
identified a protein of approximately 29 kDa in induced trophozoites. In addition a 37 
kDa protein was also observed at all examined time points (24, 48, 72, and 154 h after 
encystment was induced). Its amount increased, reaching a maximum at 72 h after 
induction. The same molecular weight protein was occasionally detected in non-induced 
trophozoites (Lopez et al., 2002). Immunoprecipitation studies demonstrated that the 37 
kDa polypeptide is a ubiquitin-bound GNP. It was proposed that GNP is ubiquitinated 
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throughout encystment in order to be degraded by the proteasome. This hypothesis was 
supported by Western blot analysis, which demonstrated various small peptides, 
representing degradation products in cultures incubated for 220 h after induction of 
encystment (Lopez et al., 2002). It could not be established which enzyme, GNP1 or 
GNP2, was present in these samples. It also was not possible to examine if the 
ubiquitinated enzyme had activity (Lopez et al., 2002). Evidence of ubiquitin-mediated 
degradation was suggested by the existence of an ubiquitin gene in the genome (Krebber 
et al., 1994) as well as characterization of a 20S proteasome complex within Giardia 
trophozoites (McArthur et al., 2000). In 2011, Elligio-Garcia et al. showed that ubiquitin 
expression was initiated 6 h after stimulation with bile along with GNP1 and CWP2 (cyst 
wall protein 2)  expression. It is worth-mentioning, however, that the authors 
unintentionally used gnp2- instead of gnp1-specific primers in their study and they 
measured expression of a ubiquitin carboxy-terminal hydrolase instead of the ubiquitin 
gene. A recent re-evaluation of transcription of GNP2 by semi-quantitative RT - PCR 
showed a low level of constitutive expression (van Keulen, personal communication). 
In summary, GNP belongs to the (2-R) aldose-ketose isomerase class of proteins. In 
human, mouse and E. coli, GNP homologs form a superfamily (Pfam PF01182) of three 
clusters. The first branch shares quaternary structure and allosteric mode of regulation by 
GlcNAc6P and contains human and E. coli enzymes. The second branch comprises the 
monomeric enzymes, and the third one is predicted to be phosphoglucolactonases (6-
phospho-D-glucono-1, 5-lactone lactonohydrolase, EC 3.1.1.31), which catalyzes the 
second step in the pentose phosphate pathway (Vincent et al., 2005).  
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We hypothesize that due to its importance for the cyst wall synthesis, GNP is post-
translationally regulated via nitrosylation in addition to the transcriptional activation. The 
question addressed here is the nitrosylation status of GNP and its effect on the enzyme. 
 
MATERIALS AND METHODS 
Two-dimensional gel electrophoresis (2-D gel) — Non-encysting trophozoites and 
trophozoites induced to encyst for 24 h were collected and processed according to the 
protocol provided by the manufacturer (FOCUS
TM
 – Soluble & Insoluble Protein 
Extraction, GBiosciences, Maryland Heights, MO). The obtained soluble fractions were 
treated using Perfect-FOCUS
TM
 (GBioscience). Protein concentrations were determined 
using the Bio-Rad (Bio-Rad, Hercules, CA) method with Bovine Serum Albumin (BSA) 
as the standard. Proteins were first separated by isoelectric focusing (IEF) using the 
ZOOM IPGRunner system (Invitrogen, Carlsbad, CA), pH 3-10, non-linear, 7 cm IPG 
strips and rehydration buffer (RB, containing 7 M urea, 2 M thiourea, 4% NP-40, 50 mM 
DTT, 1 % ampholytes and 0.002% Bromophenol Blue) according to the manufacturer’s 
instructions. Approximately 50 μg of the sample were diluted with RB to give a final 
volume of 160 μl. Samples were first applied in the mode of in-gel RB of the IPG strips 
and passive rehydration was carried out overnight at room temperature. Prior to 
rehydration, 50 mM DTT and Bromophenol Blue (3.2μl /160μl RB) were added to the 
buffer. IEF was performed at room temperature for 20 min at 200 V, 15 min at 450 V, 15 
min at 750 V and 1 h at 2000 V. The total volt-hours applied in the IEF step was 250. 
Prior to the second dimension analysis, the strips were equilibrated for 15 min in 10 ml 
equilibration solution (1 ml of 10 x sample reducing agent mixed with 9 ml of 1 x LDS 
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sample buffer (Invitrogen) and subsequently for another 15 min in 10 ml of 125 mM 
alkylation solution (232 mg of iodoacetamide in 10 ml of 1x LDS sample buffer). The 2-
D gels were blotted onto a PVDF membrane (Fisher Scientific), which was blocked 
overnight in 5% dry non-fat milk in TBS-T (Tris-Buffered Saline plus Tween-20: 20 mM 
Tris-HCl, pH 7.6, 150 mM NaCl and 0.5% Tween-20) and probed with GNP-specific 
serum using a 1: 750 dilution. 
Western blot analysis — Giardia trophozoites were collected, washed, suspended in 
the encystment medium and aliquots were placed into tubes. Encystment was carried out 
for 6, 12, 18, 24, 30, 36, 48, and 72 h. At the indicated time points encysting cells as well 
as trophozoites were collected and washed in 0.25 M sucrose. Aliquots of 10 µl were 
aspirated, suspended in formalin-PBS (as described earlier in Materials and Methods, 
Chapter II), and the cell number and percentage of fully formed cysts were determined 
using a light compound microscope. After that, cellular suspensions were centrifuged at 
12,000 x g for 2 min to remove supernatants and cells were lysed in 0.2% Triton X-100 
with protease inhibitor (GBioscience). Protein concentrations were measured using the 
Bio-Rad method. Protein lysates (15 µg of total protein per well (Invitrogen)) were 
loaded onto gradient 4 - 20 % Tris - glycine gels and separated electrophoretically. Gels 
were blotted onto PVDF membranes (Fisher Scientific), blocked overnight, and probed 
with anti-GNP serum using a 1: 750 dilution (Lopez et al., 2002).  
Enzyme assay — Lysates (6 µl) prepared from trophozoites and induced cells, 
collected at different time points after induction, were used to measure GNP activity as 
was described earlier (see chapter II). Assays were carried out at 37 
o
C for 30 min to 
measure enzyme activity (Lopez et al., 2002). The activity units obtained were 
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normalized to the activity measured in the blank (0.2 % Triton X-100) and adjusted to 15 
µg of total protein.  
Biotin – Switch Method – Cell pellets from 70 ml cultures were lysed in 5 volumes 
of buffer A plus blocking reagent as described in the S-Nitrosylation Protein Detection 
Assay Kit (Cayman Chemical Company, Ann Arbor, MI). The entire protocol described 
in the Assay Kit was followed exactly. Non-encysting trophozoites and trophozoites 
induced to encyst for 6, 12, and 24 h were pelleted and the pellets lysed, blocked and 
subjected to the biotin - switch method. One sample of non-encysting trophozoites was 
used as control for detection of possible internal biotin-labeled proteins and treated as the 
other samples except it was not subjected to the reduction/biotinylation step, but 
incubated in the same buffer without the required reagents. After acetone precipitation 
the final pellets were dissolved in 200 µl wash buffer. Protein concentration was 
measured using the Bio-Rad method.  
For analysis of nitrosylated proteins, 20 μg of proteins were subjected to 
polyacrylamide gel electrophoresis; gels were transferred to PVDF membranes, blocked 
with TBS plus 2% BSA and developed with the avidin-horseradish peroxidase, supplied 
with the kit. In addition, an avidin capture was done using avidin-agarose (Pierce, 
Rockford, IL) and 100 μg of proteins per assay, using non-encysting cells and 6, 12 and 
24 h encysting cells. The treatment and following washes were as described by Martínez-
Ruiz and Lamas (2007). Captured proteins were subjected to gel electrophoresis and 




Cloning and protein expression — The GNP was cloned in PGEX-4T-1 as described 
(Lopez et al., 2002) and expressed in BL21(DE3) (Novagen, Madison, WI) cells. Mutant 
GNPs were constructed using two mutagenic primers, one to amplify the N-end and a 
complementary one to amplify the C-end of the ORF to replace the cysteine in 
combination with the sense and antisense primers used to amplify the entire gene, see 
Table 3 for a list of the primers. In addition, unique PstI or SalI sites were introduced in 
some cases for easy detection of mutated DNA.  
TABLE 3. Primers to introduce mutations by PCR in recombinant glucosamine 6-
phosphate deaminase.  Mutations are indicated in italics in the C-end primer only; the 
following restriction enzyme sites were introduced: mutant 1: SalI, 2: SalI, 3: PstI, 4: 
SalI, 6a: SalI, 5 and 6b: none. 





Mutant 1 C219  C-end: TTAAAGGAAAGTCGACGACCCATTGCCCGG 
N-end: CCGGGCAATGGGTCGTCGACTTTCCTTTAA 
Mutant 2 C118 C-end: AAAAGGAGTCGACGCGCTATGAGCAGGAGC 
N-end GCTCCTGCTCATAGCGCGTCGACTCCTTTT 
Mutant 3 C131  C-end: TTGGCCCTGCAGATGTCTGGCTTCTGGGG 
N-end CCCCAGAAGCCAGACATCTGCAGGGCCAA 
Mutant 4 C161  C-end: GCGTCGTCGACCTGACCCAGAGCACGATCG 
N-end CGATCGTGCTCTGGGTCAGGTCGACGACGC 
Mutant 5 C234  C-end: AACATCCTCACTCGCGTTTCTATGTCGAC 
N-end GTCGACATAGAAACGCGAGTGAGGATGTT 
Mutant 6a C223 C-end: AGACCCATGTCGACGCCTCCTTCCTCCATG 
N-end CATGGAGGAAGGAGGCGTCGACATGGGTCT 
Mutant 6b C223 C-end: AGACCCATAGCCCGGCCTCCTTCCTCCATG 
N-end CATGGAGGAAGGAGGCCGGGCTATGGGTCT 
 
The polymerase chain reaction (PCR) was used with each of the mutagenic primers 
and corresponding primer for the 5’ or 3’ end of the gene using conditions as described 
(Lopez et al., 2002). The PCR generated DNAs were fractionated on a 1% agarose gel, 
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excised and purified using spin columns (Invitrogen). About 10% of each fragment was 
used for a second PCR reaction using the primers specific of expression of the entire 
gene. DNAs were denatured first for 10 min and the first DNA synthesis reaction was for 
10 min at 72 
o
C, followed by standard PCR as described. The resulting DNA was purified 
as indicated above, cloned in pGEM-T Easy for analysis of the mutated DNA and then 
after excision of the insert with EcoRI and XhoI inserted into pGEX-4T-1 as described 
for GNP (Lopez et al., 2002). Successful mutation was verified by sequence analysis of 
the pGEX clones (DNA Analysis, LLC, Cincinnati, OH).   
For isolation of recombinant enzyme overnight cultures (20 ml) with optical density 
(at 600 nm) between 0.6 – 1.0 were diluted with an equal amount of fresh medium and 
grown for 1 h in LB medium. Then, isopropyl-β-D-thiogalactopyranoside was added to a 
final concentration of 1 mM and incubation continued for 4 h. E. coli proteins were 
purified by lysing cells using B-PER
TM
 Reagent (Pierce) and lysozyme followed by 
adjusting the Mg
2+
 concentration to 10 mM with MgCl2 and addition of DNase I. Lysates 
were cleared by centrifugation in a microcentrifuge for 10 min at 12,000 RPM. 
Glutathione-S-Transferase (GST)-fusion proteins were purified on glutathione-agarose 
columns (Pierce) according to the manufacturer’s instructions. The fusion protein was 
then subjected to gel filtration over an Excellulose DF-5 desalting column (Pierce) in 50 
mM Tris-HCl, pH 8, to remove the glutathione. The collected proteins were then digested 
overnight at 20 
oC with 200 μl thrombin-agarose (Sigma). The thrombin-agarose was 
collected by centrifugation and the supernatant was then incubated with glutathione-
agarose for 15 min after which the glutathione-agarose was poured into a column and the 
eluant collected, and recycled over the column three times. These proteins were subjected 
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to gel electrophoresis to determine if the removal of the GST partner was successful. 
Protein concentrations were measured as described above. By approximation of the 
proteins on the gel, at least 90% of the GNP was recovered as GST-free protein. 
Enzyme assays with the recombinant proteins — For GNP enzyme assays, proteins 
were stored with 10% glycerol at -80 
o
C. Enzyme activity was determined in the 
aminating direction in 50 µl assays. Reactions were carried out at 37 
o
C for 30 s to 
measure initial velocity, using 0.2 μg enzyme per assay. The p-dimethylamino-
benzaldehyde (DMAB) colorimetric method was used for assays (Lopez et al., 2002). 
Standard curves were produced using glucosamine 6-phosphate; reactions were 
terminated by heating at 100 
o
C, which was followed by the addition of the color reagent 
and read at 585 nm. Each assay was performed in duplicate and repeated three or more 
times; the results presented are means of these assays. Representatives of numerous 
assays were used for data analysis because of the large variations of this method, as has 
been observed by others (Šolar et al., 2008). Km values were measured with GraFit 
software (Erithacus software version 7, Surrey, UK) and the enzyme kinetics template. 
Eight assays were averaged to produce a value. Vmax was determined from the same 
assays and was converted to µmol.min
-1
 and used to calculate the Kcat values using the 
enzyme concentration in the assay and a molecular mass of 29 kDa. For measurement of 
the effect of each mutation Lineweaver Burk plots were constructed using Microsoft 
Excel.  
In vitro nitrosylation of GNP was performed using 5 min preincubation with cys-NO 
and the entire reaction mixture on ice. Each reaction was started at 15 s time intervals so 






Expression and modification of GNP during encystment: Two-dimensional gel 
electrophoresis followed by Western blot analysis using GNP-specific serum identified a 
single spot of approximate molecular mass 66 kDa and pI 3.0 in trophozoites (Fig. 7). 
Proteins from cells induced to encyst for 24 h showed on the blot two additional spots 
and a large streak on the blot. One spot represents a protein of approximately 37 kDa 
with isoelectric point around 4 (Fig. 7, black arrow).  
 
     
 
 
Figure 7. Western blot analysis of glucosamine 6 - phosphate in trophozoites and 24 
h - encysting cells. 
Proteins from (trophozoites and cells induced for 24 h were separated by two-
dimensional gel electrophoresis and blotted onto PVDF membranes. The blots were 
probed with a 1:750 dilution of GNP-specific serum. Black arrow indicates 37 kDa 
protein in the trophozoites; white arrow indicates 29 kDa protein in 24-h encysting cells. 
                    Trophozoites                                      24 h-Encysting cells 






The other spot and the streak represented proteins of the same molecular mass, of 
approximately 29 kDa and different isoelectric points, ranging from 5 to 6 (indicated with 
a white arrow). 
Giardia trophozoites were induced to encyst and collected after 0, 6, 12, 18, 24, 30, 
36, 42, 48, and 72 h in encystment medium. Cell concentrations and the total percentage 
of fully formed cysts were determined by counting. Cells were lysed and soluble protein 
fractions were analyzed using Western blots with GNP-specific serum (Fig. 8, panel A) 
and each fraction was assayed for GNP activity (Fig. 8, panel B). Polypeptides of 37 and 
50 kDa were recognized in trophozoites, the first one corresponding to the previously 
identified ubiquitinated GNP (Lopez et al., 2004). Additional polypeptides were 
identified by GNP-specific serum in samples obtained after different encystment periods. 
A 29 kDa polypeptide, representing an inducible GNP was first identified after 6 h of 
encystment. The strength of the signal increased after 12 h and, with slight variation, was 
present throughout the entire period of encystment. The size of the inducible GNP shows 
minor changes throughout encystment, suggesting protein modification. Additional 
polypeptides of lower molecular weight (15 kDa and below) were identified at the 12, 30, 
42, and 72 h time points, suggesting protein degradation. It is worth to mention that their 
appearance corresponds to the highest percentage of cysts detected in the cultures: 34% at 
30 h, 39% at 42 h, and 57% at 72 h. The exception is 12 h which had only 2.2% of fully-
formed cysts. A polypeptide of 50 kDa was also detected at the 18, 24, 36, 42, 48, and 72 
h time points, with the strongest signal at 36 h. A polypeptide of 82 kDa was recognized 
at the 24, 30, 36, and 42 h time points, with the strongest signal at 36 h. These two 











Encystment, h:               0        6        12        18        24      30      36      42      48      72          
          Cyst, %:                0        0        2.2       5          6.9     34      28      39      38      57                                                                           
                              
Figure 8. Western blot and enzymatic analysis of glucosamine 6 - phosphate. 
(A) Analysis of lysate proteins isolated from trophozoite (0 h) and cells that had been 
induced to encyst for 6, 12, 18, 24, 30, 36, 42, 48, and 72 h. Time in the encystment 
medium and percentile of fully formed cysts at the end of the incubation are indicated 
below the image. (B) GNP activity measured per 1µg of total protein in the samples 
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Two groups of peptides, those with low molecular masses and those with 50 - 82 
kDa, were not detected in the same samples. The 15 kDa and below polypeptides 
increased in amount while those of 50 - 82 kDa decreased. GNP activity detected per 1 
µg of total protein increased throughout the encystment period with an insignificant drop 
at 30 and 42 h (the same time points that had low molecular weight polypeptides present). 
This experiment was repeated twice using two different strains of G. intestinalis. The 
results were consistent with an insignificant time-dependant variations between two 
strains. 
A.                                                          B.  
 




Figure 9. Western blot analysis of glucosamine 6 - phosphate using trophozoites 
incubated with different concentrations of NO-donor. 
Giardia cells were incubated with 1 mM (panel A) or 0.4 mM (panel B) cys-NO for 24 h. 
Cells were lysed and protein lysate was separated using SDS-PAGE along with the 
lysates of trophozoites and cells induced for cyst production. Western Blots were 
analyzed with GNP-specific serum in a 1:750 dilution. 1-trophozoites; 2-cells induced to 
encyst for 24 h; 3-trophozoites incubated with cysteine-NO for 24 h. 
 
Comparative Western blot analysis of Giardia trophozoites, induced to encyst for 24 
h, and cells incubated with the NO donor cysteine-NO (cys-NO) for 24 h was performed 
next (Fig. 9). The anti-GNP serum recognized polypeptides of 37 and 50 kDa in the 
 
 








trophozoites and cells incubated in the presence of 1 mM cys-NO and the 29 kDa 
polypeptide in the cells induced for 24 h (panel A). At the same time no polypeptides 
were identified in trophozoites or cells incubated in the presence of 0.4 mM cys-NO, 
while the 29 and 15 kDa polypeptides were recognized in cells undergoing encystment 
(panel B). 
GNP is nitrosylated in vivo: Non-encysting trophozoites and cells induced to encyst 
for 6, 12, and 24 h were used to analyze their nitrosylation state by the biotin-switch 
assay (for the details see Materials and Methods, chapter III) (Fig. 10). Biotinylated 
proteins were captured using avidin-agarose. Following extensive washing of the agarose 
beads, the samples of captured proteins, as well as the biotinylated non-captured proteins, 
were heated for 3-5 min at 80˚C in the presence of loading buffer and SDS and subjected 
to gel electrophoresis followed by Western blot analysis of the gels. The blots were 
developed using avidin-HRP and showed capture of biotinylated proteins (Fig. 10, lanes 
1 - 4) that looked essentially as samples before capture (not shown). A duplicate set of 
the blots was developed with GNP-specific serum and showed induction of GNP as a 
result of encystment (Fig. 10, lanes 5 - 8) and the presence of GNP in the avidin-captured 
samples, indicating that GNP was nitrosylated in the cells. To control for specific capture 
of biotinylated GNP both sets of blots were analyzed using a serum directed against N-
acetyl-glucosamine 6-phosphate mutase, the third enzyme in the encystment pathway, 
which has no specific (consensus) nitrosylation site. Mutase (panel A) as well as an 
anonymous cross-reacting low molecular weight protein (panel C) were present in total 
protein samples (lanes 5 - 8), but not in the captured samples (lanes 1 - 4). The mutase 
increased in amount during encystment, as expected. Both, inducible (29 kDa) and 
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ubiquitinated (37 kDa) GNP are present in total and avidin-captured samples, indicating 
nitrosylation of the enzyme in vivo upon synthesis. Several bands with molecular weight 
ranging from 30 to 34 kDa were also present.  The obtained data were reproducible upon 
repeat. 
 
                  
                 
                 
Figure 10. Nitrosylated proteins captured with avidin-agarose.  
Proteins from trophozoites (lanes 1 and 5) and cells encysting for 6 (lanes 2 and 6), 12 
(lanes 3 and 7) and 24 h (lanes 4 and 8) were subjected to the biotin-switch assay. Fifty 
µg of each assay were used for capture with avidin-agarose and loaded after binding and 
washing on lanes 1 – 4. Twenty µg of the treated proteins were loaded directly on the gel 
without capture, lanes 5 – 8. After electrophoresis, the gel was blotted onto a PVDF 
membrane which was developed with anti Giardia mutase (AGM) serum, panel A; 
deaminase (GNP) panel B; and AGM, showing a cross-reacting protein panel C. The 
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Detection of nitrosylated cysteine residues: GNP has a putative consensus 
nitrosylation motif of GKCE (Stamler et al., 1997) in position 213 - 216 (Fig. 11). In 
order to assess whether this site can be nitrosylated or not, the recombinant GNP (Lopez 
et al., 2002) was purified and the GST-fusion partner removed by thrombin digestion and 
affinity-chromatography. In addition, a mutant GNP gene was constructed with serine 
replacing cys at position 215, and then cloned and expressed in E. coli as a GST-fusion 
protein. This mutant recombinant GNP
215cs 
was purified and its GST-partner removed as 
was done for ―wild type‖ GNP. 
 
 
Figure 11. Sequence of glucosamine 6 - phosphate with cysteine sites to be mutated 
indicated in red.  
 
The amino acid sequence of GNP is shown with the mutated cysteine residues indicated 
by a red color and their position number. The three modified residues that are possible 
nitrosylation sites are marked with *. The catalytic region is underlined and the flexible 




Mutants and wild type GNPs were incubated in the presence of increasing concentrations 
of cys-NO (0 - 0.005 mM) for 2 min. Following the incubation in vitro nitrosylation was 
detected using the biotin - switch method. Equal amounts of wild type and mutant GNPs 
of each treatment were separated by PAGE and then transferred to a PVDF membrane. 
The membrane was developed with avidin-HRP (Fig. 12). Wild type GNP (panel A) as 
well as the mutant GNP
215cs
 (panel B) were biotinylated in the absence (lane 1) as well as 
presence of the cys-NO donor (lanes 2-4). The intensity of the signal, however, increased 
along with the increase in concentration of cysteine-NO (cys-NO) up to 0.05 mM (lanes 
2, 3).  The results indicate that both wild type and mutant GNP can be nitrosylated in 
vitro.   
                                                                       
                                      
Figure 12. Comparative biotin-switch analysis of wild type and mutated GNP.     
Wild type (panel A) and mutant CS215 (panel B) GNP were incubated with increasing 
concentration of cysteine-NO (lane 1-0 mM; 2-0.5 mM; 3-0.05 mM; 4-0.005 mM). 
Recombinant proteins nitrosylation was assayed using the biotin-switch method. 
 
To evaluate the effect of nitrosylation on GNP the kinetic parameters Km and Vmax of 
the enzyme incubated in the presence or absence of cys-NO were measured. The Km of 
the recombinant enzyme (without cys-NO treatment) was 3.5 ± 0.18 mM with fructose 6-
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values of the Km changed depending on the NO donor concentration (data not shown).  
The Km increased up to 7.7 mM at high cys-NO concentrations (0.4 mM), but decreased 
to 1.9 - 1.12 mM with 0.2 mM to 0.002 mM cys-NO. For routine comparison, 0.002 mM 
(2 µM) cys-NO was selected. The average Km of several independent measurements was 
1.5 ± 0.85 mM. The Vmax did not change much in these assays. Without nitrosylation the 
Vmax was 90 µmol/min/mg and was 80 µmol/min/mg in the presence of 2 µM cysteine-
NO. A typical Lineweaver-Burk plot is shown in Fig. 13. The Km in the absence of cys-










Figure 13. Effect of nitrosylation on catalytic parameters of recombinant GNP.  
Recombinant GNP (0.4 µg) was assayed for 30 s in 50 µl at 37
o
C with fructose 6-
phosphate (F6P) as substrate (0.5 – 32 mM) without (circles) or with 2 µM Cys-NO 
(triangles). The results are presented as a Lineweaver-Burk plot. The vertical axis (1/V) 





























Figure 14. Effect of nitrosylation on catalytic parameters of recombinant mutant 
GNP. Mutant GNPs (0.4 µg) were assayed for 30 s in 50 µl at 37
o
C with fructose 6-
phosphate (F6P) as substrate (0.5 – 32 mM) without (circles) or with 2 µM Cys-NO 
(triangles). The data are presented as representative Lineweaver-Burk plots. A: mutant 
C
113




. The vertical axis (1/V) is in arbitrary units, the horizontal 




























The effect of nitrosylation on mutant GNP
215cs
 was investigated in the same manner. 
The Km was 2.5 ± 0.75 mM. In the presence of cys-NO the Km decreased to 1.2 ± 0.3 
mM, which suggests that nitrosylation has the same effect on the Km of the mutant as it 
had on the Km of the wild type GNP. This result suggested strongly that mutant GNP
215cs
 
is not nitrosylated at position 215, as the biotin - switch experiment already indicated 
since this mutant was biotinylated as strongly as the wild type GNP. 
Therefore, to evaluate the possibility that other cysteines could be nitrosylated, 
several separate mutations were introduced in positions: 113, 126, 156, 219, and 230. 
These positions represent cysteine residues flanking the catalytic region of GNP (Fig. 
11). In addition a double mutant (position 113 plus 230) was constructed. All mutants 
were cloned and expressed in E. coli and the expressed proteins were purified and treated 
as described above. The kinetic parameters of all these mutants were measured in the 
presence and absence of 2 µM of cys-NO. Representative Lineweaver-Burk plots for all 
mutants are shown in Fig. 14. The ratio of Km in the absence and presence of 2 µM cys-
NO was used as an indication of the effect of the mutation. A ratio close to one will 
indicate the loss of the effect of nitrosylation on the catalytic properties of GNP, because 
of a loss of a cysteine that could be nitrosylated. The values for Km and Vmax were 
calculated as an average of 5 - 10 assays for each mutant.  
A summary of the results, including the ratio of Km values in the absence and 




 showed Km 
ratios similar to wild type GNP, namely 2.3 ± 0.28 and 3.9 ± 1.75 similar to wild type, 





 lost their response to nitrosylation. Their Km 
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ratios with and without cys-NO are 1.0 ± 0.08 and 1.2 ± 0.16 and representative 
Lineweaver-Burk plots show a minimal effect on Km values and are shown in Fig. 14 
(panel B). To a lesser extent mutant GNP
113cs
 showed some effect of nitrosylation with a 
Km ratio of 1.2 ± 0.17 and a representative Lineweaver-Burk plot is shown in Fig. 8 
(panel A).  
                       
Figure 15. Effect of nitrosylation on catalytic parameters of recombinant mutant 
C219 GNP. 
Mutant C219b GNP (0.4 µg) was assayed for 30 s in 50 µl at 37
o
C with fructose 6-
phosphate (F6P) as substrate (0.5 – 32 mM) without (circles) or with 2 µM Cys-NO 
(triangles). The data are presented as Lineweaver-Burk plots. The vertical axis (1/V) is in 
arbitrary units, the horizontal axis is in 1/[S] in 1/mMF6P. 
 
Mutation of the cysteine in position 219 of GNP to a valine and the proline of 
position 220 to aspartate, to introduce a restriction site in the mutant for easy selection, 
however abolished enzyme activity completely at the concentrations used for the assays. 







enzyme compared to the standard assay was incubated for 10 min. Because this mutation 
introduced a negatively charged residue, another mutation was made changing C219 into 
S219. This still resulted in an enzyme with very low activity (Fig. 15) and kinetics that 
made measurement of a Km impossible. The GNP mutant carrying a double mutation in 
cysteine 113 and 230 behaved similar to their single mutants (Fig. 16).  
 
 
Figure 16.  Effect of nitrosylation on catalytic parameters of recombinant GNP 
carrying double mutation at positions C113 and C230. 
Double mutant GNP (C113 and C230) was assayed for 30 s in 50 µl at 37
o
C with fructose 
6-phosphate (F6P) as substrate (0.5 – 32 mM) without (circles) or with 2 µM Cys-NO 
(triangles). The data are presented as representative Lineweaver-Burk plots. The vertical 
axis (1/V) is in arbitrary units, the horizontal axis is in 1/[S] in 1/mM F6P. 
 








Table 4. Comparison of kinetic parameters of recombinant and mutant glucosamine 
6 - phosphate. 
The ratio of Km + and – cys-NO is per pair-wise comparison of each individual assay. 
The averages are of duplicates repeated 3 times for C126 and C156 to 6 times for the 
other mutants. GNP wt represent wild type enzyme. 
 
Effect of nitrosylation on the catalytic parameters of GNP: As shown in the previous 
section, GNP can be nitrosylated and two cysteines (156 and 230) identified as candidates 
for nitrosylation. The relevance of these positions will be discussed later. To see what the 
effect of nitrosylation might be a more accurate determination of Km and Vmax values is 
needed than the use of double reciprocal plots. These were useful to detect the effect of 
mutations but for an accurate measurement of the catalytic parameters the assays done 






























































































GNP wt --------- 3.5 ± 1.1 1.5 ± 0.85 137 ± 53.5 115 ± 38.9 2.9 ± 1.36 
Mutant 2 C113 2.8 ± 0.96 2.0 ± 0.67 136 ± 48.0 91 ± 29.7 1.2 ± 0.17 
Mutant 3 C126 3.3 ± 0.98 2.1 ± 0.24 187 ± 102.6 173 ± 92.9 3.9 ± 1.75 
Mutant 4 C156 1.3 ± 0.32 1.3 ± 0.26 198 ± 48.0 282 ± 22.1 1.0 ± 0.08 
Mutant 1 C215 2.5 ± 0.75 1.2 ± 0.29 215 ± 139.1 212 ± 113.1 2.3 ± 0.28 
Mutant 5 C230 2.6 ± 0.98 2.8 ± 0.35 118 ± 64.3 111 ± 68.8 1.2 ± 0.16 
Mutant 2+5 C113+ 
230 
1.8 ± 0.47 2.4 ± 0.95  0.8 ± 0.20 
Mutant 6 C219 Not active 
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Vmax  using the Michaelis Menten equation. The values obtained were used to calculate 
Kcat and Kcat/Km of recombinant GNP in the absence or presence of an NO donor. 
Table 5. Catalytic parameters of wild type GNP 
 In the absence of 
NO 
In the presence of NO 
(2 µM) 
Km 2.7 ± 0.44 mM 1.2 ± 0.45 mM 
Kcat 42 ± 11 s
-1













       In addition assays were performed as described above using a 5 min preincubation 
with cys-NO and also by treating GNP with cys-NO followed by removal of cys-NO by 
gel filtration. Both treatments had similar effects. The obtained values of Kcat/Km are 
shown in Table 5. The ratio of Kcat/Km in the presence of nitrosylation and without 
nitrosylation is on average 2. Also the ratio Vmax/km was calculated as the physiological 
catalytic efficiency as used by Moreno-Sánchez et al., (2008). Again the ratio of these 
constants before and after nitrosylation is on average 2. This indicates that the enzyme 
becomes twice as efficient after nitrosylation. 
 
DISCUSSION 
Glucose is needed for energy and cyst wall production. GNP is the first and the key 
enzyme in the Giardia encystment pathway. The substrate of the enzyme is F6P, which 
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also is an intermediate of glycolysis, one, of at least two energy producing pathway in 
Giardia trophozoites. GNP is regulated at the gene level by transcriptional activation 
(Lopez et al., 2003) and converts F6P and NH4
+
 (supplied by the arginine dihydrolase 
pathway) to glucosamine-6-phosphate (GlcN-6-P) (Macechko et al., 1992; Morrison et 
al., 2007). GlcN-6-P, the product of the first reaction in cyst wall synthesis, also serves as 
an allosteric regulator for the fourth enzyme in the encystment pathway: UDP-N-
acetylglucosamine pyrophosphorylase (Fig. 5), which is constitutively expressed in 
Giardia trophozoites (Bulik et al., 2000). Glycolysis is ubiquitous and a highly conserved 
metabolic pathway: its main control point in most organisms is the enzyme 
phosphofructokinase (PFK), which catalyzes a rate-limiting step of F6P phosphorylation, 
the third irreversible reaction in this pathway. The enzyme is allosterically regulated by 
AMP/ATP concentrations in most organisms (Bagyan et al., 2005). In contrast the 
glycolytic pathway in Giardia relies on a pyrophosphate (PPi)-dependent PFK, which 
makes this reaction reversible (Li and Phillips, 1995; Mertens, 1991). However, the 
Kcat/Km for PPi is two orders of magnitude larger than the Kcat/Km for Pi (the reverse 








 for Pi (Li and Phillips, 1995). 
Both Giardia enzymes, constitutively expressed PFK and transcriptionally activated 
GNP, use the same substrate, F6P. The source of F6P is glucose obtained from 
endogenous reserves as shown by Macechko et al. (1992), who also showed that glucose 
is diverted towards glucosamine during encystment. Giardia PFK has a Km of 
0.25±0.0196 mM (Li and Phillips, 1995) while GNP has a Km of 2.5±0.24 mM (Steimle 









 for GNP (Phillips, personal communication), thus the catalytic efficiency is 18 times 
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better for PFK. This clearly is a paradox, so the regulatory question becomes how is the 
switch from the use of glucose for glycolysis to its use in the encystment pathway for 
giardan synthesis accomplished biochemically? Note that the increase in GlcN-6-P during 
encystment as the result of GNP activity is approximately 5 fold (Şener et al., 2009). 
Previously it was suggested that the difference in Km is simply overridden by the 
drastically increased amount of GNP (Jarroll et al., 2001). In this case glycolysis will 
have to slow down or maybe even stop to accommodate the high demand on glucose in 
the form of F6P for encystment. Therefore, energy production in the form of ATP 
synthesis must come from another pathway, supposedly from ADHP (this will be 
discussed later). In conclusion, down-regulation of glycolysis downstream from F6P 
would be expected if the catalytic efficiency of GNP is not sufficient to redirect F6P 
towards cyst wall biosynthesis. Since PFK itself is not allosterically regulated in Giardia 
another enzyme might be involved. 
Could nitrosylation be the key regulatory mechanism? The logical consequence of 
NO production by Giardia (observed by Harris et al., 2006) is modification of parasitic 
proteins by a post - translational addition of an NO moiety to cysteine. This modification 
has been shown to alter protein activity or function. The best examples are hemoglobin, 
several caspases, dimethylarginine dimethylaminohydrolase, but what might pertain to 
the situation in Giardia, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (Hess et 
al., 2001; Leiper et al., 2002; Shenton and Grant, 2003; Kuncewicz et al., 2003) is 
another possibility. The example of human GAPDH modification is well documented 
(Mohr et al., 1996; Mohr et al., 1999; Mannick, 2007). By analyzing protein databases 
Stamler et al. (1997) proposed a putative motif composed of acidic and basic amino acids 
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to predict cysteines prone to nitrosylation. The postulated consensus sequence is a 
cysteine surrounded by proton donor and acceptors that looks like this: ([G,S,T,C,Y,N,Q] 
[K,R,H,D,E] C [D,E]). In a later publication, the same author modified the idea of a 
consensus to a more general acid/base motif in which the tertiary structure also is needed 
to provide the acids/bases (in aquaporin, for instance) and the cysteine might even be in a 
non-polar sequence, as is the case for the ryanodine receptor (Hess et al., 2001). The idea 
of a consensus sequence also has been challenged later by Marino and Gladyshev (2009) 
using a comparison of known nitrosylated proteins. The immediate flanking of acidic 
residues appeared not to be critical although distant acidic groups still might play a role 
(Marino and Gladyshev, 2009). Based on the above, the working hypothesis is that 
GAPDH might be involved in the control of glycolysis through inactivation by 
nitrosylation.  
Is GNP nitrosylated? The possibility of GNP modifications that might affect protein 
activity and localization was demonstrated by two-dimensional gel electrophoresis. 
Earlier it was shown that Giardia proteins undergo post - translational modifications by 
phosphorylation (Alvarado and Wasserman, 2010; Ellis et al., 2003; Slavin et al., 2002), 
glycosylation and palmitoylation (Hiltpold et al., 2000; Webera et al., 1997), 
isoprenylation (Luján et al., 1995), ubiquination (Lopez et al., 2002), and SUMOylation 
(Touz et al., 2008). Originally two native isoforms of GNP were purified; both had 
molecular masses of 29 kDa, one with pI of 7.1 and 7.3 (Steimle et al., 1997). However, 
more isoforms, including the one with a higher molecular weight are annotated in the 
Giardia data base (Morrison et al., 2007). The spot of 66 kDa, identified by GNP-specific 
serum in Giardia lysates separated by 2-D gel electrophoresis (Fig. 7) could be a result of 
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serum cross-reactivity with one of the high molecular weight GNP-like protein (this one 
has a calculated pI of 5.56; note that the IEF gels used were not linear and determination 
of the pI is not accurate). The protein spots with molecular weights 29 and 37 kDa 
respectively, correspond to the inducible GNP and GNP modified by ubiquitin 
attachment. The streak that was observed shows that GNP is abundant in the induced 
cells and also is subjected to a different kind of modification. Phosphorylation as well as 
nitrosylation would cause protein mobility shifts. Usually the shift is large when the pI of 
a protein is 7 or above and negligible when the pI is around 5 (Zhu et al., 2005). 
Calculation of the pI of GNP using the program of Halligan (2009) revealed a pI of 6.69, 
which changes to 6.51 with one phosphate added, 6.36 with two and 6.23 with three 
phosphates. Phosphorylation with a high score (≥0.8-0.9) was predicted for GNP1 at 
serine positions 107, 146, 150, 202, and 210, and for threonine at position 187. The GNP 
2 sequence also showed the possibility of phosphorylation with a high score at serine 
positions 13, 161, 165, and 217, and threonine positions 202. Analysis was performed 
using NetPhos 2.0 server on gGNP2 (Blom et al., 1997). 
Nitrosylation can shift the pI 0.6 units higher than the pI without modification as 
shown by Kim et al. (2004) for Iron Regulatory Protein 2 which shifted from a pI of 6.4 
to 7.0 after nitrosylation. Giardia proteins show a high degree of modification shown by 
a proteomics analysis (Su et al., 2007). GAPDH was present as two spots on 2-D gels, 
one with a pI of 6.9, which is the calculated pI, one with a pI of 7.5 (calculated using the 
gels shown in the authors’ figure). This could be the result of nitrosylation. Other proteins 
present as two spots were phospoglycerate kinase, glutamate dehydrogenase, and 
ornithine carbamoyl transferase. Phosphoglycerate kinase shows an extra spot with a 
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lower pI, suggesting phosphorylation; the other two enzymes both show a second spot 
with a higher pI than the calculated ones. When the Giardia database (Morrison et al., 
2007) was searched for the consensus nitrosylation motif as described above ornithine 
carbamoyl transferase as well as GNP and a number of other metabolic enzymes (in the 
pentose-phosphate pathway and in the ADHP) exhibited them. The putatively identified 
nitrosylation consensus sequence in GNP was a cys at position 215, in the sequence 
GKCE.  
The method of choice for detecting nitrosylated proteins, the biotin – switch, was 
developed by Jaffrey et al. (2001). This method is based on blocking free thiol groups by 
methylation, followed by reducing a nitrosylated cysteine to a thiol which is then labeled 
with activated biotin. This method was applied to Giardia lysates and many proteins were 
biotinylated suggesting that they originally contained nitrosylated cysteine residues. One 
problem reported by others is that some thiol groups might not be accessible to the 
blocking reagent. One way to overcome this problem is denaturation of proteins in the 
presence of SDS, which can also destroy the unstable nitrosothiols (Forrester et al., 
2009). However, under these stringent conditions still many proteins in Giardia were 
biotinylated suggesting that nitrosylation of Giardia proteins indeed takes place (data are 
not shown). Capture of the biotinylated proteins with avidin-agarose and their analysis 
using GNP-specific antiserum identified GNP among these nitrosylated proteins. 
In summary, the ubiquitinated (constitutive, modified) enzyme appears to be 
nitrosylated in vivo and the induced enzyme can be artificially nitrosylated in vitro. 
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Is GNP nitrosylation a part of the metabolic switching mechanism? GNP contains 
the consensus nitrosylation sequence proposed by Stamler (1997) and appeared to be 
nitrosylated in vivo. Nitrosylation of GNP was postulated as a mechanism to help 
regulate GNP activity. Such modification could account for F6P redirection from 
glycolysis to cyst wall synthesis. To test this hypothesis, in vitro nitrosylation of 
recombinant GNP was performed and activity was measured at various concentrations of 
the substrate F6P in the presence or absence of cys-NO. Initial assays showed that 
nitrosylation had little if any effect on the enzyme activity, therefore, fixed amounts of 
cys-NO were tested with F6P concentrations ranging from 0.5 – 32 mM in order to 
measure the effect of nitrosylation on the Km of the enzyme. High concentrations of cys-
NO (0.2 and 0.4 mM) increased the Km, indicating a lower affinity for the substrate. 
However, a low concentration of cys-NO of 2 µM decreased the Km of the enzyme from 
about 2.5 mM to 0.7 mM in one typical assay, indicating an increased affinity for the 
substrate. The implication is that the enzyme could reach Vmax at a much lower substrate 
concentration, making it plausible that it could redirect F6P usage towards cyst wall 
polysaccharide biosynthesis at a fixed F6P concentration. The fact that the NO 
concentration increases during early encystment (Timothy Paget, personal 
communications) would support this conclusion (see Fig. 20, Chapter IV). The largest 
effect on GNP Km was found when 2µM cys-NO was used for 5 min. While it is not 
possible to say at this time which NO concentration would be the closest to the natural 
one, physiological concentrations of NO are quite low as described by Hall and Gartwaite 
(2009) and ranges from as low as 100 pM to 5 nM. The results of a large number of 
assays show consistently that the GNP Km becomes smaller upon nitrosylation. The effect 
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of nitrosylation on the Vmax of the reactions was quite variable, but on average it was 
lower. The resulting Kcat/Km ratio increases only by a factor of 2.  
GNP nitrosylation resulted in a twofold increase in catalytic potential. Taking into 
account that the amount of enzyme also increases because of transcriptional activation, 
this might be sufficient to account for the switch to the encystment pathway. Because 
there are no data available on metabolite flow and especially the concentration of F6P in 
the cells, this conclusion might be premature. Maybe the increase in enzyme quantity is 
already sufficient to account for the above mentioned switch. In addition, the down-
regulation of GAPDH might slow glycolysis sufficiently to assist in redirection of 
carbons toward cyst wall production. Then the question arises, why nitrosylation? One 
possibility is that nitrosylation is used to control the amounts of GNP. Nitrosylation could 
be the signal to start the ubiquination of the enzyme. From the results of the 2-D gels, it is 
clear that the enzyme is modified during encystment. In fact the ―smeary pattern‖ could 
be due to nitrosylation and/or phosphorylation. In either case this modification could 
serve as a signal for the ubiquination observed previously (Lopez et al., 2002). It is not 
clear why the enzyme is ubiquitinated. The data provided by the above mentioned authors 
do not indicate if the enzyme is inactivated.  
Why is GNP ubiquitinated? In 2002, Lopez et al. demonstrated that GNP is 
ubiquitinated upon induction of encystment. Ubiquitinated GNP (37 kDa protein) along 
with immuno-reactive small peptides was the only form of the enzyme present in 
encysting cells for longer periods of time (48 h - 72 h) and in formed cysts. 
Ubiquitination typically targets enzymes for proteasomal degradation. Although poly-
ubiquination (Fang and Weissman, 2004; Winget and Mayor, 2010) is usually required 
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for recognition by the proteasomal complex, mono-ubiquination was demonstrated as 
sufficient signal for degradation in some systems (Kravtsova-Ivantsiv et al., 2009). 
Ubiquitinated GNP was occasionally detected in non-induced Giardia trophozoites. 
Such inconsistency could be explained by the absence of synchronization in Giardia cell 
cultures and the observation that some trophozoites encyst even when they are not in 
ideal encystment conditions (Sulemana et al., personal communication). The other 
possibility is that ubiquination followed by degradation is a way to regulate/neutralize the 
effect of a continuous but low level of transcription present in Giardia (Vanacova et al., 
2003). The biotin - switch method showed that both the ubiquinated as well as the 
unmodified enzyme were nitrosylated. Additionally, some other forms of the enzyme, 
possibly partially degraded proteins, were also present as nitrosylated. This assay does 
not allow for quantitation of the amount of nitrosylation or for measurement of the 
percentage of nitrosylated enzyme in the total lysate, so the effect of nitrosylation on 
enzyme activity is not easily measurable.  
Lysine residues, prone to ubiquitin attachment, could also be targeted by SUMO. 
The resulting SUMOylation usually protects the protein from ubiquitin-dependent 
proteasomal degradation and the modified protein acquires a novel function. Touz et al. 
(2008) demonstrated SUMOylation of Giardia’s arginine deiminase (gADI). It (gADI) is 
the first enzyme in the ADHP and catalyzes the irreversible catabolism of arginine to 
citrulline (Schofield et al., 1990; Schofield et al., 1992). Additionally, gADI serves as a 
peptidylarginine deiminase that converts protein-bound arginine to citrulline and by that 
regulates antigenic shift in Giardia (Touz et al., 2008). Finally, gADI is SUMOylated and 
translocated to the nucleus in the cells induced to encyst.  
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The exact lysine, targeted by ubiquitin attachment in GNP was not detected. Using 
ubiquination prediction software, K 111 and K 265 (Fig. 6) were identified as possible 
modified residues, K 111 with a low and K 265 with a moderate confidence level 
(Radivojac et al., 2010). Different lysine residues were identified by SUMOylation 
prediction software. Among them K 95, that carries the consensus sequence Ψ-K-X-E, 
and two lysines at positions K 203 and K 265 as non-consensus sequences (Ren et al., 
2009). Analysis of the protein sequence of GNP2 did not identify a site for ubiquination, 
however, it showed a very high score (3.19) for SUMOylation at position K 110 
(consensus sequence Ψ-K-X-E).   
In summary, GNP appears to be regulated via nitrosylation in addition to the 
previously reported regulation by transcriptional activation and ubiquitin attachment 
(Lopez et al., 2002; Lopez et al., 2003). The finding that both forms of the enzyme appear 
to be nitrosylated suggests that this modification precedes ubiquination. The recombinant 
GNP can be expressed as an active enzyme with the correct specificity, which made it 
possible for use in vitro nitrosylation experiments to predict the effect of nitrosylation on 
the native enzyme. In vitro nitrosylation using cys-NO, an NO donor that exchanges the 
NO group from soluble cys-NO to thiol groups in proteins assumes that a similar reaction 
takes place in vivo. Nitrosylation reduces gGNP’s Km for F6P two-fold. A change in Km 
and increase in the amount of enzyme during encystment could increase the flow of F6P 
from glycolysis to the encystment pathway. It is not clear if in vitro nitrosylation mimics 
precisely in vivo nitrosylation, but nitrosylation of the native and recombinant enzymes 
in the presence of cys-NO was demonstrated by the biotin - switch method. Additionally 
GNP could be modified also by phosphorylation and SUMOylation as is suggested by the 
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shift in the pI in 2-D gel electrophoresis and the modification prediction software used. 
The exact mechanism and consequences of the demonstrated modifications are not 
known. As suggested by the results of Western blot analysis performed on the cells 
undergoing encystment, the amount inducible gGNP (29 kDa) activity increased 
throughout the ―active‖ encystment phase (6 - 24 h). At the same time the protein 
molecular mass increases due to ubiquitin attachment. After 24 h, when most cells in the 
culture have finished encysting, the products of protein degradation appear along with a 
decrease in the amount of ubiquitinated GNP.  
Is the cysteine in the consensus sequence nitrosylated? The question of which 
cysteine(s) is/are modified was addressed by in vitro mutation of cysteine residues close 
to the active site in the E. coli enzyme. Cysteine does not play a role in the catalytic 
mechanism of the E. coli enzyme, although two cysteine residues (C 118, comparable to 
C 113 in Giardia and C 239) are involved in allosteric control (Lucumí-Moreno et al., 
2005; Oliva et al., 1995). C 239 is not conserved in the Giardia enzyme, but C 230 is 
close to the C 239 in the E. coli enzyme. First position C 215 was mutated because it is 
part of the consensus sequence suggested by Stamler et al. (1997) and was replaced with 
a serine. The mutant enzyme behaved essentially the same as the non-mutated enzyme, 
indicating that other residues must be nitrosylated and this also suggested that this 
consensus sequence is not critical, as has been shown by others (Marino and Gladyshev, 
2009). Therefore, a number of other cysteine residues were mutated (Fig. 11). These are 
close to the active site and one, C 230, is close to the C 239 involved in allosteric 
regulation in the E. coli enzyme. Mutations in C 126 showed no effect, the enzyme 
behaved as the wild type enzyme. Mutation of C 230 made the enzyme not responding to 
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nitrosylation, suggesting that this is a major controlling residue. Some effect was 
observed in the mutant that had C 113 modified. A double mutant with both C 113 and 
230 modified completely abolished response to cys-NO. In addition, modification of C 
156 abolished the effect of nitrosylation, so it appears that C 156 and C 230 are the main 
target sites for nitrosylation with C 113 as a tertiary site. MS data support the notion that 
between two and four sites can be nitrosylated with a certain degree of variability 
(Timothy Paget, personal communications). Modification of C 219 could not be studied 
because it resulted in complete loss of enzyme activity when the C was mutated to a V 
followed by a D replacing the P 220. Another mutant that had the C 219 replaced for a 
serine only was active but showed a low activity and unusual kinetics. This suggests that 
C 219 might be involved in the catalytic mechanism. Modeling of the enzyme using 
SWISS-MODEL (Fig. 17) showed that this C 219 is close to the catalytic H 138 and E 
143 in the active site, which residues are involved in a proton relay in the E. coli enzyme 
(Horjales et al., 1999) and are conserved in the Giardia enzyme as well (van Keulen et 
al., 1998). The mechanism by which nitrosylation affects the enzyme kinetics might be 
through a conformational change in the enzyme (Lucumí-Moreno et al., 2005; Oliva et 
al., 1995). The Giardia enzyme is active as a monomer (Steimle et al., 1997) in contrast 
to the E. coli enzyme which is a hexameric enzyme that shows allosteric control through 
the allosteric effector N-Acetyl-glucosamine 6-phosphate (Oliva et al., 1995).  
However, the gGNP might have retained the ability to undergo conformational 
changes. In the E. coli enzyme E 148, D 141 and H 143 form a proton relay (Oliva et al., 
1995). E 148 neutralizes positive charges in the allosteric site, but after the allosteric 
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effector binds, the phosphate in it takes over this role and makes the E available for the 
proton relay (Horjales et al., 1999). 
 




Figure 17. Model of the GNP active site before mutation (panel A) and after 
mutation of C-P to V- A in the positions 219-220 (panel B).   
Aminoacids His 138 and Glu 143 involved in the catalysis are shown (Altamirano et al., 
1992; Oliva et al., 1995). 
 
The charge change after nitrosylation of recombinant gGNP might have a similar 
effect and, in that manner, changes the Km of gGNP. It is intriguing to speculate that 
nitrosylation of C 156 and C 230 are critical because both are localized close to the 
allosteric site identified in the E. coli enzyme’s crystal structure (Oliva et al., 1995). 
C156, in particular, is interesting because it is located in the flexible lid, covering the 
active sites, identified in the E. coli enzyme as two antiparallel β-strands connected by a 
loop-helix-loop structure (Lucumí-Moreno et al., 2005) from position 158-187. This 
corresponds to region 153 - 183 in gGNP. The allosteric site made up of L 160 and T 161 
(Lucumí-Moreno et al., 2005) in this flexible lid is in Giardia GNP identical to V 155 
and C 156. C 113 on the other hand is on the surface of the enzyme (Altamirano et al., 





In summary, despite the monomeric nature gGNP behaves like an allosteric enzyme. 
This agrees with the notion that allostery is the result of a conformational change in a 
protein due to binding of a ligand or any change in the protein, such as a covalent 
modification. The effector binds at a site away from the active site (allosteric site) and 
affects the catalytic rate of the enzyme. This is an intrinsic property of all monomeric 
proteins and thus also the one subunit enzyme such as GNP falls in this category as has 
been described by Goodey and Bekovic (2008) in their review on allosteric regulation. 
The major finding is, therefore, that nitrosylation could act as an allosteric control 




















ANALYSIS OF NO-SYNTHESIZING ACTIVITY IN GIARDIA 
INTRODUCTION 
The importance of NO and protein modification by NO attachment was discussed 
earlier (see Chapter I). Here the question is: What is the source of NO in Giardia? There 
are two ways that NO may be produced: enzymatically and non-enzymatically (Fig. 18). 
Non-enzymatically, NO is produced from nitrite by reducing compounds, such as 
NADPH, L-cysteine, ascorbate, reduced glutathione and other thiols. Enzymatically NO 
is produced from L-arginine by NO synthase (NOS) in the presence of oxygen. The 
enzyme catalyses formation of NO as well as transfer of NO from S-nitrosocysteine 
(Ischiropoulos, 2005).  Three classes of NOS have been identified in mammals: neuronal 
(nNOS), or NOS 1, epithelial (eNOS) or NOS 3, and inducible (iNOS) or NOS 2. The 
first two enzymes are produced in animal tissues constitutively and regulated by the 
intracellular Ca
2+
 level as well as phosphorylation. At the same time iNOS is a Ca
2+ 
independent enzyme produced by macrophages upon stimulation with 
lipopolysaccharides or other potentially damaging stimuli. It is regulated transcriptionally 
or via nitrosylation (Hausel et al., 2006; Gaston et al., 2003; Mitchell et al., 2005).  
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NO2- + 2 H
+ + e- NO + H2O  
                              
Figure 18.  NO production by nitrite reduction (panel A) and enzymatically by NOS 
from arginine (panel B). Panel B image is copied from the protocol for NOS activity 
assay kit (Promega). 
 




M and is strongly affected by the 
extracellular redox state. The amount of NO produced by iNOS is higher and may reach 
up to 10 μM, the toxic level for the cell (Hernández-Campos et al., 2003). The biological 
half life of NO varies from milliseconds to hours, depending on the concentration and 
presence of thiols. For protection, nitrosothiols must be stored in lipophilic protein folds, 
vesicles and interstitial spaces. For example, activation (denitrosylation) of caspases 
occurs upon release from mitochondria to the cytosol (Gaston et al., 2003; Mitchell et al., 
2005). Typical NOS is a homodimer, consisting of an oxygenase or oxygen-binding and a 
reductase domain (Fig. 19) (Mitchell et al., 2007). The catalytic domain has an arginine-, 
tetrahydrobiopterin- (whose role remains elusive) and a zinc tetrathiolate-binding site. 
The reductase domain has a FMN, FAD, and NADPH – binding site. Ca2+ /Calmodulin 
activates transport of electrons from the reductase domain to the N-terminal oxygenase 






Figure 19. Domain structure of human iNOS (courtesy of Alderton et al., 2001).  
Oxygenase and reductase domains are indicated by solid boxes with the amino acid 
residue number shown at the start/end of the domain. The cysteine residue that ligates the 
Haem and Calmodulin (CaM) –binding site are indicated in black. Zink (Zn)-binding site 
is indicated in grey.  
  
Nonconventional NOS-like enzymes have been found in plants, for instance in 
Arabidopsis thaliana, as well as in protozoa such as P. falciparum, E. histolytica, 
Leishmania donovani, Toxoplasma gondii, Trypanosoma sp. (Basu et al., 1997; 
Crawford, 2006; Gutierrez-Escobar et al., 2008; Hernández-Campos et al., 2003; Paveto 
et al., 1995).  
As was mentioned in Chapter I, the Giardia database (McArthur et al., 2000) has a 
gene annotated as iNOS, however, it encodes only the reductase-like domain of the 
typical human iNOS. The active consumption of external arginine resulting in 89 % 
convertion into ornithine within 4 sec was documented by Knodler et al. (1995). The 
evident consumption of arginine via ADHP by Giardia was demonstrated by Schofield et 
al. (1990). This pathway converts arginine to ornithine and ammonium with a 
concomitant ATP production via substrate level phosphorylation (Schofield et al., 1990). 
ADHP is present in many prokaryotes, while Giardia and Trichomonas are the only 
eukaryotes identified so far that have the pathway (Linstead and Cranshaw, 1983; 
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Schofield et al., 1992). ADHP operates via three enzymes: arginine deiminase (ADI), 
ornithine transcarbamoylase (OTC), and carbamate kinase (CK). The activity of all three 
of these enzymes resulted in an 80-fold higher arginine flux through Giardia than in 
Trichomonas (Schofield et al., 1992). OCT was proposed as a candidate for the rate 









 from 1 mM glucose in 
glycolysis (Schofield et al., 1992). Furthermore, arginine catabolism is not in conflict 
with glycolysis and mainly operates during the active proliferative stage (Schofield et al., 
1992). The ADHP function during encystment has never been studied, although 
additional properties of ADI, the first enzyme in the pathway, in encysting and non-
encysting trophozoites were recently identified (Touz et al., 2008). In non-encysting 
trophozoites, ADI also appeared to function as a peptidylarginine deiminase performing 
citrullination of variant-specific surface proteins. This activity plays an important role in 
Giardia antigenic shift which allows the parasite to evade the host’s immune system 
(Touz et al., 2008). In encysting cells, ADI is SUMOylated and translocated to the nuclei. 
Downregulation of CWP 2 expression was registered in the cells overexpressing ADI 
(Touz et al., 2008).  The authors speculate that there are two possible explanations for 
ADI SUMOylation: 1) downregulation of the enzyme activity through sequestration from 
the cytoplasm; 2) transcription regulation through histone citrullination (Touz et al., 
2008). OCT on the other hand seems to be nitrosylated as was discussed earlier (see 
Chapter III). Besides, it seems to be regulated through the same signaling pathway as CK, 
GAPDH and CWP 1-3 as suggested by Su et al. (2007). The present hypothesis is that 
Giardia actively uses the ADHP in the initial hours of encystment (first 6 h), later the 
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parasite might switch to the use of arginine for NO synthesis, but this is speculation. The 
ADHP is regulated through post-translational modification of ADI and OCT. The former 
is SUMOylated and sequestered from the cytoplasm as it was demonstrated by Touz et al. 
(2008). The latter is probably subjected to nitrosylation as is suggested by the presence of 
a putative nitrosylation motif and by the findings of Su et al. (2007). The switch between 
arginine conversion to citrulline and arginine use for NO production could be 
differentiated on the basis of the presence of NADPH. None of the ADHP reactions 
require NADPH, while arginine conversion to NO is NADPH dependent (see Fig. 3). 
In summary, it was demonstrated that G. intestinalis produce NO, however so far 
there is no evidence of active NOS. The goal of this section of the dissertation is to study 
the NO- synthesizing activity in trophozoites and cells induced to encyst.  
 
MATERIALS AND METHODS 
 
Detection of Nitric Oxide — NO production by encysting and non-encysting Giardia 
trophozoites was estimated spectrophotometrically as formed nitrite (NO2
-
) using the 
Griess Reagent System (Promega). Briefly, cells were treated as indicated (see Chapter 





PBS with arginine (0.5 mM) and incubated for 1 h at 37 
o
C. Cells were then removed by 
centrifugation at 2500 x g. To measure nitrite formed, 500 μl of the supernatant were 
incubated with 500 μl of Griess reagent at room temperature for 10 min, then the 
absorbance was measured at 543 nm using a Perkin Elmer 1420 Multilabel Counter 
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microtiter plate reader. The nitrite content was determined from a calibration curve using 
NaNO2 performed in parallel with the samples.  
In vivo NO detection — In order to detect NO production in vivo 2,3-Diamino 
Rhodamine (DAR-1 (Sigma)) was used. Harvested and washed trophozoites from normal 
growth medium with or without arginine (5 mM) and NADPH (100 nM) or trophozoites 
encysting for 6 h (treated the same way) were incubated with DAR-1 at a final 
concentration 10 µM for 40 min. A separate group of 6 h-induced and non-induced cells 
was incubated with 7.7 µM cys-NO and used as a positive control.  Cells were processed 
as discussed earlier (see Chapter II) and observed with a Deltavision deconvolution 
microscope using Olympus 10X0.40 optics and Rhodamine-Texas Red- Phycoerythrin 
(RD-TR-PE) and 4',6-diamidino-2-phenylindole (DAPI) specific filters. All 
manipulations with cells labeled with DAR-1 were performed at reduced light.  
IFA performed on induced or cys-NO treated cells using Cyst Wall specific serum 
and Jacalin — Non-induced or cells induced for 6, 10, 18, 24, 30, and 36 h as well as 
cells induced to encyst for 6 h in the presence of 50 µM cys-NO were harvested and 
processed as discussed earlier (Chapter II). Cells attached to a slide were incubated with 
Cyst Wall specific serum (1:1000 dilution) (Erlandsen et al., 1990). After rinsing, the 
slide was incubated with a 1:1000 dilution of secondary antibody conjugated to 
tetramethyl rhodamine isothiocyanate (TRITC). After that the slide was rinsed and then 
incubated with fluorescein isothiocyanate (FITC)-conjugated Jacalin (Vector 
laboratories) at a final concentration 10 µg.ml
-1
. All the antibodies/Jacalin incubations 
were performed for 1 h at 37 
o
C. All the manipulations with the cells followed incubation 
with the primary antibodies were performed under reduced light. Cells were observed 
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with a Deltavision Deconvolution microscope using Olympus 10X0.40 optics and RD-
TR-PE and FITC-specific filters. 
Detection of intracellular NO and protein nitrosylation levels — NO production by 
encysting and non-encysting Giardia trophozoites was estimated spectrophotometrically 
as formed nitrite (NO2
-
) using the Griess Reagent system (Promega). To measure the 
intracellular level of nitrite, cells were resuspended in HEN buffer (Schonhoff and 
Benhar, 20011) to a final volume of 1 ml, 10 µl of suspension was aspirated and fixed in 
a total volume 1 ml of formaldehyde-PBS (Repasky at al., 1982) to account for the cyst 
percentage. Cells were then broken using Molecular Grinding Resin and pestles 
(GBioscience). The lysate obtained was centrifuged at 12000 x g for 2 min and 50 µl of 
supernatant was used per assay. Assays were performed in quadruplicate. Each 
supernatant aliquot was incubated with 50 µl of sulfanilamide solution with or without 
0.2% HgCl2 (Schonhoff and Benhar, 20011). After 5 min incubation 50 µl of NED 
solution was added to the mixture and following 5 min incubation the absorbance of the 
formed azocompound was measured with a Perkin Elmer 1420 Multilabel Counter 
microtiter plate reader with a 570 nm filter for 1 sec. Reactions were carried at room 
temperature with reduced light. The protein concentration was measured using the 
Bradford reagent (Amresco). The readings obtained were normalized using a NaNO2 
calibration curve (the standards were tested in parallel with the samples) and protein 
concentrations. The formed nitrite amount was presented as µM per 1 mg of total protein.  
Conversion of arginine — For the conversion of arginine to citrulline by the ADHP, 
the NOS Activity Assay Kit from Cayman Chemical Company was used. Radiolabeled 
arginine, 250 μCi of L-(2,3,4,5 [3H]) arginine-HCl was obtained from GE Healthcare 
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(Piscataway, NJ). The kit measures the conversion of arginine to citrulline in crude 
protein extracts because the arginine is selectively bound by a resin and removed by 
using spin columns. The remaining radioactivity as citrulline was collected and counted 
in a Beckman scintillation counter. The assay was tested by using the supplied 
recombinant human iNOS and a specific iNOS inhibitor NG-nitro-L-Arginine (L-NNA). 
In the control reactions, performed as described by the manufacturer, recombinant iNOS 
converted 90% of the arginine supplied to citrulline but only 10% in the presence of the 
inhibitor. Protein lysates were prepared as described in Chapter II. Non-induced, 6 h- 
induced and 24 h- induced cells were used and 10 μg of protein was used per assay. The 
assay consisted of 25 μl 2 x reaction buffer, 1 μCi arginine in a total volume of 50 μl and 
reactions were incubated at 37 
o
C for 30 min. The reactions were terminated by adding 
400 μl stop buffer and processed as suggested by the manufacturer of the test kit. The 
percentage of conversion to citrulline was calculated as cpm reaction – cpm blank 
divided by the total cpm input times 100. 
Measurement of NO-synthesizing activity — Giardia trophozoites and cells induced 
to encyst for 6 h were lysed in 50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 50 mM NaCl and 
0.2% Triton X-100 with protease inhibitor (GBioscience). The mixed lysates were 
fractioned on a Sephadex G-150 column with 50 mM Tris-HCl pH 8 as buffer and 
fractions of 500 µl were collected. Separated fractions were measured for NO-
synthesizing activity using 4,5-Diaminofluorescein (DAF-2) (Cayman). Originally assays 
were performed in the presence of NADPH, however due to the absence of an effect of 
NADPH it was omitted from following assays. Briefly 10 µl of each fraction was 
incubated in 200 µl assay mixture containing 25 mM Tris-HCl pH 8 and 0.1 µl of DAF-2 
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(5 mM in DMSO) for 30 min at 37 
o
C. Fluorescence was measured with a Perkin Elmer 
1420 Multilabel Counter microtiter plate reader and filter setting of 485/535 nm, the 
value with assay buffer only was subtracted. After initial fluorescence detection the most 
―active‖ fractions were pooled and separate aliquots were heat-treated 10 min at 90 oC or 
assayed in buffers with different pH values. 
RNA isolation and analysis — RNA was isolated and subjected to RT-PCR as 
described by van Keulen et al. (2008). The primers were designed based on the DNA 
sequence of giNOS, GNP and glutamate dehydrogenase (GDH) (as loading control (Touz 
et al., 2008)) to amplify the entire ORF. Reverse transcription coupled polymerase chain 
reaction (RT-PCR) was used to synthesize cDNA from total RNA (0.5 μg) using each 
gene specific antisense primer, and Moloney Murine Leukemia virus reverse 
transcriptase (Epicentre, Madison, WI) according the manufacturer's protocol in a 20 μl 
reaction.  
Table 6. giNOS- and GDH-specific primers.  
 PRIMERS 
giNOS Forward 5’ AAAGGGGAATTCCTGAGCATAGTGTATG 
Reverse 5’ CTAATATGCCTCGAGGTGAACTCTATTC 
GDH Forward  5’ ATGCCTGCCAGACGATCATCGA 




The cDNA obtained was heated for 15 min at 90 
oC and then treated with 1 μl RNase 
((Invitrogen) for 30 min at 37 
o
C. Then 10% of the cDNA was subjected to the 
polymerase chain reaction (PCR) using these gene specific primers and Taq DNA 
polymerase as described (van Keulen et al., 1998).  
Semi-quantitative RT-PCR (comparison of 18, 25 and 32 cycles of the PCR reaction) 
using RNA from non-induced and 6 h-induced cells was used to investigate whether 
mRNA was present or up- or down-regulated. The PCR-generated DNA was analyzed on 
a 1% agarose gel and stained with ethidium bromide. The primers for giNOS and GDH 
are shown in the Table 6.  
The same primers also were used for cloning of giNOS. Cloning was performed as 
previously described for GNP (see Chapter III).  For GNP amplification primers 
previously used for enzyme cloning in pGEX-4-T-1 were used (Lopez et al., 2002).  
 
RESULTS 
Detection of NO production throughout encystment: The preliminary results 
obtained by Dr. Timothy A. Paget (personal communication) showed that non-encysting 
trophozoites of MR4 produced NO at approximately 15 nmol/min/10
6
 cells. During 
encystment (6 - 12 h) this number significantly increased up to 23. By 24 h, NO 
production had significantly diminished to one-fifth the maximum NO produced (Fig. 
20). Upon 1 h incubation with 0.5 mM arginine the final yield of NO increased 4 - 5 fold.  
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NO production in trophozoites and cells induced to encyst for 6 h was also examined 
using 2,3-Diamino Rhodamine (DAR-1). 
         
Figure 20. NO production by Giardia trophozoites during encystment. 
NO production by cells induced to encyst for 0, 6, 12, and 24 h was measured using the 
Griess assay. Cells were incubated with or without 5mM arginine for 1 h and total NO 
production measured. The percentage of encystment after 24 h induction was 56%. Black 
boxes represent NO production in the presence of 5 mM arginine; white boxes represent 
NO production without arginine. The insert shows the increase of percentage of 
encystment during this time period. The bars represent standard deviation of the mean 
(SD) (Courtesy of Dr. Timothy A. Paget).   
     
The amount of NO in non-induced trophozoites was below detection level (Fig. 21; 
A), but a significant increase in the signal was measured and mostly concentrated in the 




incubation with 5 mM arginine or arginine in combination with 100 nM NADPH, an 
NO-generated signal appeared in non-induced cells and increased in induced cells (Fig. 
21; B-C, F-G). The captured signal had a punctate pattern spread throughout the cell and 
concentrated in the perinuclear space. Non-induced trophozoites incubated with an NO 
donor (cys-NO) generated a signal similar to that produced by induced cells and cells 
incubated with arginine plus NADPH (Fig. 21; D). When induced trophozoites were 
incubated with cys-NO the strength of the signal increased (H).  
 
                 
      
                
 
Figure 21.  Detection of in vivo produced NO using DAR-1. 
Giardia cells (panels A and B) were incubated with DAR-1 for 40 min. Panel A 
represents Giardia trophozoites; panel B represents Giardia trophozoites induced to 
encyst for 6 h. Additionally cells were incubated with 5 mM arginine alone, or in 
combination with 100 nM NADPH and with 7.7 µM cysteine-NO 
 
                                 5 mM arginine      5 mM arginine      7.7 µM cys-NO   
                                                                100 nM NADPH 
                                 5 mM arginine      5 mM arginine      7.7 µM cys-NO   





      
NO induces morphological changes in Giardia: In order to study the in vivo effect of 
NO, Giardia trophozoites were incubated with various concentrations of cys-NO. Cells 
were analyzed using cyst wall specific serum (1:1000) and Jacalin (10 µg/ml) using IFA. 
The images were compared with the images generated from non-induced  












Figure 22. Indirect immunofluorescence of induced and cysteine-NO treated cells 
using cyst wall specific serum and Jacalin. 
Giardia trophozoites non-induced (A) or induced to encyst for 5-10 (B), 18-24 (C), 30-36 
(D) h, and induced to encyst for 6 h as well as incubated in the presence of 50 µM cys-
NO (E) were subjected to IFA using cyst wall specific serum at 1:1000 dilution (detected 






  trophozoites              5-10 h induction          18-24 h induction 
30-36 h induxtion       6h induction + cys-NO            




trophozoites or cells induced to encyst for various lengths of time after reaction with the 
same serum and the lectin. Cyst wall specific antiserum did not generate any signal in 
non-induced trophozoites (Fig. 22); a few dots recognized by Jacalin appeared to be non-
specific. The signal showing the punctate pattern spread throughout the cytosol and 
concentrated to the periphery when the assay was done on cells obtained after incubation 
of 5 - 10 h in the encystment medium. The Jacalin-generated signal was spread 
throughout the cytosol. After 18 - 24 h in the encystment medium the signal generated 
by the cyst wall serum and Jacalin overlapped in the center of the forming cyst’s body, 
and only the cyst wall specific signal was detected on the periphery of the cyst (Fig. 22; 
C). After 30 - 36 h in encystment medium the signal obtained with Jacalin was almost 
lost, while anti-cyst wall serum produced a typical image of fully formed cyst with a 
solid surface and a single ―tail‖ (Fig. 22; D). Cells incubated in maintenance medium 
with various concentrations of cys-NO (the result of only one concentration: 50 µM is 
shown) resembled fully-formed cysts after a 6 h induction period. The ―cysts‖ produced 
as result of incubation with 50 µM cys-NO (Fig. 22; E) had atypical shapes and a 
―swollen‖ tail pattern. The pattern obtained with the cyst wall serum and the Jacalin-
generated signal was also different. The signal generated with Jacalin was mostly 
concentrated in the central part (as in the case of 5 - 10 h of induction), while both 
signals overlapped on the periphery of the ―cyst‖ body and the ―tail‖.  
 Analysis of protein nitrosylation throughout encystment: To evaluate the amount of 
nitrosylated proteins in Giardia throughout the encystment period, non-induced (0 h) and 
induced trophozoites (6, 16, and 24 h) were harvested and lysed to obtain soluble 
proteins. Cells were broken using Molecular Grinding Resins and pestles and identical 
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soluble fractions were treated with the Griess reagent in the presence and absence of 
HgCl2, a reagent that reduces S-nitrosothioles into nitrites (Schonhoff and Benhar, 
2011).  
              
Figure 23. Protein nitrosylation throughout encystment. 
Giardia trophozoites non-induced (0 h) or induced for 6, 16, and 24 h were broken using 
Molecular Grinding Resins and pestles. Nitrosothioles were reduced to NO2
-
 using HgCl2, 
total nitrite level was determined using Griess reagent. The percent of fully formed cysts 
present in the culture after each time point is indicated on the top of the bars in the panel. 
White bars represent NO present in the medium as nitrite, black bars represent bound NO 
that was reduced to nitrite. MM-maintenance mediun, EM-encystment medium. The 
experiment was performed three times in triplicate and bars represent SD.  
 
The amount of nitrosylated proteins was estimated as the difference between the 
nitrite amounts detected in the presence versus absence of HgCl2. The results obtained 
were quantified using a nitrite standard curve and normalized by protein concentrations 




















from 72.9±2.5 to 102.3±6.7 µM immediately upon transferring cells from maintenance 
to the induction medium (Fig. 23). In the first 6 h of encystment this number increased to 
155.9±2.7 µM), and stayed almost the same between 6 and 24 h induction.  
Arginine conversion in Giardia during encystment: In order to detect arginine 
conversion by giNOS an assay method that uses radioactive arginine was employed 
(Moncasa and Higgs, 1993; Nathan and Xie, 1994). Addition or omission of NADPH was 
used to differentiate between giNOS and ADI activities. The arginine conversion in 
Giardia lysates is presented as percent of citrulline obtained compared to the initial 
arginine input.  Arginine conversion did not depend on NADPH and was 41.8 ± 8.1 % in 
trophozoites, while increased up to 80.6 ± 8.7 % during the first 6 h of encystment. 
Towards 24 h of encystment this number dropped to 66 ± 5.8 % (Fig. 24).  
         
Figure 24. Arginine conversion in Giardia trophozoites and cells induced to encyst 
for 6 and 24 h.  
The final amount of radiolabeled citrulline was measured in lysates of Giardia 
trophozoites and cells induced to encyst for 6 and 24 h. The amount converted is shown 






















Detection of NO-synthesizing activity: In order to detect NO-synthesizing activity 
Giardia protein lysates were subjected to gel-fractionation on a Sephadex G-150 column. 
The fractions were assayed for NO-producing activity, using DAF-2 reagent, which emits 
fluorescence only upon reaction with NO. 
        
Figure 25. Effect of pH and heat inactivation on Giardia NO-synthesizing activity. 
Giardia lysates of trophozoites and cells induced to encyst for 6 h were subjected to 
fractionation on Sephadex G-150. Fractions were assayed for NO-producing activity. The 
active fractions were pooled and NO-synthesizing activity was measured using DAF-2 
after a variety of treatments in the presence (lanes 3, 5, 7, 9) or absence (lanes 2, 4, 6, 8) 
of arginine (0.5 mM) and compared to the blank (lane 10). Lane 1- heat inactivated for 10 
min at 90˚C; lanes 2, 3- pH 6.8; lanes 4, 5-pH 7.3; lanes 6, 7-pH 8.0; lanes 8, 9- pH 9.0.    
  
The fractions showing NO-producing activity were pooled and either treated with heat 
(90 
o
C) for 10 min or incubated in buffers with a different pH (pH of 6.8; 7.3; 8.0; and 
9.0 were selected). The intensity of fluorescence, corresponding to NO-producing 
activity, was measured in the treated fractions and normalized with respect to the blank. 



















also was evident from the results that the NO-producing activity did not depend on the 
presence of arginine (Fig. 25).  
Analysis of putative Giardia NOS: Anti-giNOS serum was generated using the 
immunogenic C-terminal peptide CGPANDAVDTSNKVI (Fig. 26). The peptide was 
selected by the manufacturer. Pre-immune and giNOS-specific sera were tested on 
Western blots and by indirect immunofluorescence analyses (IFA). Giardia lysates 
(trophozoites and encysting cells) were subjected to differential centrifugation to separate 
soluble (S) and two particle-associated fractions (P1, (unbroken cells, nuclei, fragments 
of flagella and adhesive disks and P2, large particle fraction (Lindmark, 1988)). E. coli 
BL21 cells expressing GST-giNOS and His-tagged giNOS were lysed and the 
recombinant GST and His-tagged proteins were purified as described (see materials and 
methods). Giardia trophozoites (total lysate, fractions S, P1, and P2) and 24 h-encysting 
cells (fraction P1) samples as well as purified GST-giNOS were separated using SDS-
PAGE and transferred to PVDF membranes. The membrane was probed with preimmune 
(data not shown) and anti-giNOS sera in a 1:1000 dilution (Fig. 27; panel A). Preimmune 
serum was tested along with anti-giNOS serum in each assay and did not give non-
specific signals (Fig. 28). The predicted molecular masses of giNOS, GST-fused giNOS 
and His-tagged giNOS are 66.6 kDa, 92.6 kDa, and 69.1 kDa, respectively.  
The giNOS-specific serum showed a polypeptide of approximate molecular mass of 
84 kDa, which agrees with the size of the recombinant GST-giNOS and some minor 
bands of 50 - 60 kDa (Fig. 27; panel A; lane 1). When total Giardia proteins were 
subjected to Western blot analysis the anti-serum reacted with a few polypeptides with 
molecular masses of 30, 44, 46, and 50 kDa (lane 2).  
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giNOS  1   -----------------------------------------------------------    0          
NOS 2  1   MACPWKFLFKTKFHQYAMNGEKDINNNVEKAPCATSSPVTQDDLQYHNLSKQQNESPQPL   60  
giNOS  1   -----------------------------------------------------------    0               
NOS 2  61  VETGKKSPESLVKLDATPLSSPRHVRIKNWGSGMTFQDTLHHKAKGILTCRSKSCLGSIM   120 
giNOS  1   -----------------------------------------------------------    0             
NOS 2  121  TPKSLTRGPRDKPTPPDELLPQAIEFVNQYYGSFKEAKIEEHLARVEAVTKEIETTGTYQ  180  
giNOS  1   --------------------------------------------- MALSIVYATVGGTA   14           
NOS 2  181  LTGDELIFATKQAWRNAPRCIGRIQWSNLQVFDARSCSTAREMFEHICRHVRYSTNNGNI  240                                                           
giNOS  15   R----------------------------------------------------------N  16            
NOS 2  241  RSAITVFPQRSDGKHDFRVWNAQLIRYAGYQMPDGSIRGDPANVEFTQLCIDLGWKPKYG  300                                                                                                   
giNOS    17   LAHKIAALLDSRGIATQLYDVKN-------------------------------------   39              
NOS 2    301  RFDVVPLVLQANGRDPELFEIPPDLVLEVAMEHPKYEWFRELELKWYALPAVANMLLEVG   360              
giNOS  40   -------------------IRTLEDLPTGDLLYLTS------THGLG------------   61      
NOS 2  361  GLEFPGCPFNGWYMGTEIGVRDFCDVQRYNILEEVGRRMGLETHKLASLWKDQAVVEINI  420       
 giNOS    62   --------------QHPQSAHALMKSLKQQSK---------------------------   79          
NOS 2    421  AVLHSFQKQNVTIMDHHSAAESFMKYMQNEYRSRGGCPADWIWLVPPMSGSITPVFHQEM  480        
giNOS   80   ------------------------------------------------------------  79       
NOS 2   481  LNYVLSPFYYYQVEAWKTHVWQDEKRRPKRREIPLKVLVKAVLFACMLMRKTMASRVRVT  540    
giNOS   80   ----------------------------------------------------------PG   81     
NOS 2   541  ILFATETGKSEALAWDLGALFSCAFNPKVVCMDKYRLSCLEEERLLLVVTSTFGNGDCPG   600                                                                 
giNOS   82   PRHWLNKREANPQLLGSSRRIAVLGIGSIKYHQFCAASQDAVAVFKSHSIPTLVEP----   137         
NOS 2   601  NGEKLKKSLFMLKELNNKFRYAVFGLGSSMYPRFCAFAHDIDQKLSHLGASQLTPMGEGD   660                       
giNOS   138   ------------------IHLDTSELETGLQLWVKKFLTAIGTTDSHVLDVPVRKLGEEN  179           
NOS 2   661   ELSGQEDAFRSWAVQTFKAACETFDVRGKQHIQIPKLYTSNVTWDPHHYRLVQDSQPLDL  720              
giNOS    180  ---LADLSENTLFDPRITESTLLSATMLSSFGWIYHLHVPSTLSPMLVPGAHIAVYPRIE   236        
NOS 2    721  SKALSSMHAKNVFTMRLKSRQNLQSPTSSRATILVELSCEDGQGLNYLPGEHLGVCPGNQ   780                      
giNOS    237  ESMINRLLDLGVLT-LHDTSIDSTAFIQIDSPHDPDLPADPISIVDLLSRVCNVNAKPSY   295        
NOS 2    781  PALVQGILERVVDGPTPHQTVRLEALDESGSYWVSDKRLPPCSLSQALTYFLDITTPPTQ   840              
giNOS    296  NLISFLAPYATTSEDKFKLKYLTEDAVLFDILSYQWPTIYDFLLDFSSLRIPLGKFLRVC   355         
NOS 2    841  LLLQKLAQVATEEPERQRLEALCQPSEYSKWKFTNSPTFLEVLEEFPSLRVSAGFLLSQL   900               
giNOS    356  PRIDPRLYSVASLPHPDEDSNTVCTVDLLVGNPKPRNGHSIQNSLGPSYLQRALISNEPI   415         
NOS 2    901  PILKPRFYSISSS---RDHTPTEIHLTVAVVTYHTRDGQGPLHHGVCSTWLNSLKPQDPV   957    
giNOS    416  RIAILQNQFLSDSGLTMLLGGKTALIGVAFGSGFAPFRAYHELRSAIASMDGVETLAPYL   475        
NOS 2    958  PCFVRN-----ASGFHLPEDPSHPCILIGPGTGIAPFRSFWQQRLHDSQHKGVRGGRMTL   1012  
giNOS    476   LLLS-IPHAEPQLLEELRRDVENGVINVVLCLTRDDG-------TDNQGKGLDIDSFTSA   527         
NOS 2    1013   VFGCRRPDEDHIYQEEMLEMAQKGVLHAVHTAYSRLPGKPKVYVQDILRQQLASEVLRVL   1072                      
giNOS    528  HGTFLHIYKG---KRMGDVIHSSSIPDRLLRDLNRPDLSVYYCGP-ANDAVDTSNKVIEN   583        
NOS 2    1073 HKEPGHLYVCGDVRMARDVAHTLKQLVAAKLKLNEEQVEDYFFQLKSQKRYHEDIFGAVF   1132 
giNOS    584  MVGAEKYRTMRSENRVHVEAY                                          604    
NOS 2    1133 PYEAKKDRVAVQPSSLEMSAL                                          1153  
Figure 26. Sequence alignment of Giardia annotated inducible NOS (giNOS) and 
human inducible NOS (NOS 2). 
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Identical amino acid are indicated by ―*‖, conserved substitutions by ―:‖, semi-conserved 
by ―.‖.The oxygenase domain is indicated as a bold box, while the reductase domain is 
indicated by colored boxes. The sequences responsible for binding of FMN and 
FAD/NADPH are indicated by grey and orange colors, respectively (Based on Alderton 
et al., 2001). The immunogenic peptide used for giNOS serum production is identified by 
red font. 
 
                                    
 
                                    
 
Figure 27. Western blot probed with giNOS specific serum. 
Giardia trophozoites and encysting cells were lysed and subjected to differential 
centrifugation to obtain soluble (S), and two particle-associated fractions (P1 and P2). 
The obtained fractions as well as the lysate of bacterial cells expressing GST-fused 
giNOS and purified recombinant giNOS were separated using SDS-PAGE and 
transferred to PVDF membranes. The membrane was probed by giNOS specific serum at 
1:1000 dilution (Panel A) and 1:2000 dilution (Panel B). Panel A: 1-purified GST-
giNOS; 2- G. intestinalis trophozoites, total lysate; 3- S fraction; 4- P1 fraction; 5- P2 
fraction;  6- G. intestinalis, 24 h induction of encystment, P1 fraction. Panel B: P2 
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Some additional bands showed a low-intensity signal but disappeared when the 
serum was diluted 2000 fold (Fig. 27; panel B). Two of the above mentioned bands (50 
and 46 kDa), with a lower intensity, were seen in the soluble fraction (lane 3). The same 
bands as well as an additional one of 30 kDa were present in the P1 (lane 4) and P2 (lane 
5) fractions and gave a strong signal. 
The anti-giNOS serum recognized an additional polypeptide of 70 kDa in fraction 
P2, this band was present in lower intensity in the S fraction, but absent from the P1 
fraction. In the particulate fraction of 24 h-encysting cells (lane 6), the serum reacted with 
bands of 46 kDa and 37 kDa (specific for 24 h). To ascertain the specificity of the 
antibodies, a competition experiment was performed by using the peptide to which the 
antiserum was generated (Fig. 28). The anti-giNOS-specific serum was incubated with 
increasing concentrations of the immunogenic peptide (panels C-H) prior to incubation 
with the membranes. The strength of the signal obtained was compared to the signal of 
preimmune serum (panel A), and anti-giNOS serum with no peptide added (panel B). The 
bands recognized by the anti-serum in the lanes containing recombinant GST-giNOS and 
His-tagged-giNOS (lanes 1 and 2) were decreasing in intensity with increasing 
concentrations of the peptide and disappeared when the serum was competed with 100 µg 
peptide.  
The giNOS specific serum gave a signal of a punctate pattern, that was mostly 
concentrated to the periphery of cells in trophozoite and spread throughout the cytosol  in 
cells undergoing encystment for 6, 12, and 18 h (Fig. 29). The strength of the signal 
increased during encystment and at 24 h was also localized to the periphery of the cells. 
Preimmune serum was tested along with the giNOS-specific one and occasionally also 
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would give a weak signal with a punctate-pattern (12 h, panel A). In a competition study 
(Fig. 30) giNOS-specific serum was incubated with increasing concentrations of the 
immunogenic peptide prior to IFA.  It was shown that the strength of the signal changed a 
little but did not depend on the peptide concentration. 
 
 
            
 
 
Figure 28. Western blot analysis of giNOS with serum previously incubated with the  
immunogenic peptide. 
Purified GST-giNOS (lane 1) and HIS-tagged giNOS (lane 2) as well as the lysates of 0 
(lane 3) and 6 h (lane 4) induced Giardia cells were separated by SDS-PAGE and 
transferred to a PVDF membrane. The membrane was probed with preimmune serum 
(panel A), and giNOS specific serum at 1:2000 dilution (panels B - H), previously 
incubated with different concentrations of the immunogenic peptide. Peptide 
concentrations: panel A – 0 µg; B - 0 µg; C - 100 µg; D – 10 µg; E – 1 µg; F - 0.1 µg; G -
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Figure 29. Indirect immunofluorescence of Giardia trophozoites and encysting cells 
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Figure 30. Indirect immunofluorescence of encysting Giardia cells using giNOS 
specific serum preincubated with immunogenic peptide. 
Giardia cells undergoing encystment for 12 h were probed with giNOS-specific serum 
previously incubated with different concentrations of the immunogenic peptide: panel    






















Semi-quantitative RT-PCR analysis of giNOS expression: To analyse expression of 
giNOS in trophozoites and induced to encyst for 6 h cells, we performed RT-PCR using 
GDH and GNP as an example of a genes expressed in constitutive and inducible manner. 
The results demonstrate that giNOS is expressed in a very low level in trophozoites (Fig. 
31: panel A (top), lane 3) with a slight increase upon encystment (Fig. 31; panel B (top), 
lanes 2-3). As expected, GDH was constitutively expressed. Surprisingly, GNP 
expression was detected in trophozoites when higher amount of amplification cycles were 
used (panel C (top), lanes 2-3). However, in comparison to panel D (top), lane 1 showed 
that GNP expression is induced upon encystment. The absence of tight regulation during 
expression in Giardia was discussed earlier (Vanacova et al., 2003).      
                     
 
Figure 31. Comparative expression analysis of giNOS, GDH, and GNP using RT-
PCR.  
RNA from non-induced trophozoites (panel A and C) and trophozoites induced to encyst 
for 6 h (panels B and D) were used in RT-PCR with the primers specific to the following 
genes: giNOS (panel A-B; top), GDH (panel A-B; bottom); GNP (panel C-D; top). For 
the reverse transcriptase control we used the following parimers: giNOS (panel C; 
bottom), and GDH (panel D; bottom). Different number of cycles was used in the PCR: 
lane 1: 18, 2: 25, and 3: 32 cycles. 
                A                     B                       C                       D 







Nitric oxide production in Giardia: NO is an important physiological messenger, 
involved in the homeostasis of cardiovascular tissue and regulation of neuronal signal 
transduction and immune response in higher eukaryotes (Bredt and Snyder, 1994; 
Dawson and Dawson, 1995). In prokaryotes NO is involved in the regulation of gene 
expression (Cutruzzola, 1999; Spiro, 2006; Zumft, 2002). While NO production was 
discovered in such protozoa as P. falciparum, E. histolytica, L. donovani, T. gondii, 
Trypanosoma sp. and recently in Giardia intestinalis and T. vaginalis, its effect/function 
is not well understood (Basu et al., 1997; Crawford, 2006; Gutierrez-Escobar et al., 2008; 
Harris et al., 2006; Hernandez-Campos et al., 2003; Paveto et al., 1995). The half life of 
NO is measured in miliseconds which makes its detection extremely difficult. One means 
to investigate NO formation is to measure nitrite (NO2
-
), which is one of two primary and 
stable products of NO breakdown (Schonhoff and Benhar, 2011). Using the Griess 









 cells) in 
the first 6 h of encystment. This is the period of active synthesis of the protein involved in 
cyst wall synthesis and its regulation. This is also the time when GNP transcripts were 
detected first (van Keulen et al., 1998). DAR-1 staining in indirect immunofluorescence 
showed that the amount of NO increased after 6 h of encystment. DAR-1 is a membrane-
permeable fluorescent indicator based on the rhodamine chromophore. Upon interaction 
with NO, DAR-1 is converted to a fluorescent trizol (McQuade, L.E., Lippard, S.J. 
(2010)). The presence of a strong fluorescent signal in the perinuclear area of undergoing 
encystment cells indicates nitrosylation of newly synthesized proteins. The fluorescent 
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signal increased when non-induced cells were incubated with arginine alone, or arginine 
with NADPH, which indicates that arginine serves either as a substrate for NO 
production or affect NO production indirectly through the ADHP. Incubation of non-
induced trophozoites with cys-NO also resulted in a strong fluorescent signal and was 
used as a positive control.   
The Griess reagent also was used to evaluate the intracellular level of NO in the form 
of nitrite. In order to assess the amount of NO present in the form of nitrosyl groups 
HgCl2 was used to reduce nitrosothioles and convert the bound NO into nitrite. The level 
of nitrosylated proteins was evaluated as a difference of the presence of NO2
-
 without and 
with HgCl2. To monitor encystment the total cell amount and the amount of fully formed 
cysts in the samples were calculated. The level of nitrosylated proteins increased 
immediately after cells were transferred to the encystment medium, while the level of 
free NO did not change significantly. This indicates that the switch in culture medium 
induces NO production and this NO is used to nitrosylate the proteins present. Further 
during the first 6 h of encystment both cellular NO and nitrosylated protein levels 
continue to increase (Fig. 20, 23). This observation agrees with the data obtained earlier 
by Timothy A. Paget. During the first 6 h of encystment Giardia cells actively synthesize 
proteins involved in cyst wall production; this is the time when transcripts of GNP and 
CWP 1 - 3 are first detected (Luján and Touz, 2003). This finding along with the IFA 
results indicate that Giardia NO-synthesizing activity increases in the first 6 h of 
encystment and the NO is produced used to nitrosylate several proteins. During the next 
10 h of encystment the level of nitrosylated proteins as well as the total NO level 
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fluctuate insignificantly (155±2.7 - 160±5.1 µM) showing a slight increase at 24 h 
(181±15.1 µM). At this time nitrosothiols were present in a low amount. 
What is the function of internal NO in Giardia? According to the results obtained so 
far, Giardia actively synthesize NO at the initial stage of encystment and use it as a 
signaling mechanism during encystment. GNP, the first enzyme in the giardan 
biosynthesis, is one of the proteins suggested to be nitrosylated.  
To evaluate the possibility of encystment as a result of incubation with cys-NO, cyst 
wall specific serum and a lectin specific for (β-1, 3) N-acetylgalactosamine (Roque- 
Barreira and Campos-Neto, 1985) were used in indirect immunofluorescence. The 
morphological changes observed were compared to the transformations of cells induced 
to encyst for 5 - 10, 18 - 24, and 30 – 36 h. It is interesting to observe the change in the 
pattern of the signals produced by the cyst wall-specific serum and Jacalin throughout the 
process of encystment.  At the earlier stage (5 - 6 h, not shown) the cyst wall signal has a 
punctate pattern that increases in strength and spreads towards the periphery when 
encystment comes closer to the 10 - 12 h mark (Fig. 22; B). This signal at this time point 
coincides with CWP 1 - 3 synthesis, which are delivered to the encysting cell periphery 
by encystment specific vesicles (ESV (see Fig. 4; Chapter 1)), as was demonstrated 
earlier (Luján and Touz, 2003). The signal obtained with Jacalin is mostly spread 
throughout the cell cytoplasm, which is in agreement with localization of the cyst wall 
synthesizing activity to the cytosolic fraction (Luján and Touz, 2003). At the later stage 
of encystment (18 - 24 h) an overlap of Jacalin and cyst-wall specific signals was 
observed. These findings are in agreement with earlier demonstrated strong interactions 
between polysaccharides and proteins in the actively growing cyst wall (Chavez-Munglia 
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et al., 2007). The Jacalin signal is diminished in the fully formed cysts (Fig.22, D). This 
is probably explained by the unavailability of free (β-1, 3) N-acetylglactosamine on one 
hand and outcompeting action of cyst-wall specific serum on the other hand. The 
opposite picture can be observed in the cells treated with cys-NO for 6 h. The Jacalin 
signal is strong and spreads throughout the cytosol as well as to the periphery of the cell 
and the ―tail‖. The cyst wall specific signal is less strong and localized to the periphery if 
present (Fig. 22, E). The cyst ―body‖ seems less compact and is irregular. Most probably 
cys-NO induces the synthesis of the carbohydrate moiety of the cyst wall, but not the 
protein one (concluded from the absence of ESV-associated signals). This results in 
defective cysts.  
In summary, NO production is detected in Giardia. The amount of produced NO 
dramatically increases during the initial 6 h of encystment, which suggests the 
importance of this molecule for the process of encystment. It is still not clear if NO 
directly participates in regulation of encystment-specific gene expression, however, the 
increase in the amount of nitrosylated proteins suggests regulation of protein activity via 
post-translational modification and may be change in intracellular localization.   
Is giNOS responsible for the NO production? Originally NO production in Giardia 
trophozoites was documented and measured by Harris et al. (2006). They estimated NO-




 and attributed it to the NOS (ORF 91252) 
annotated as such in the Giardia database.  
The gene for giNOS was cloned and expressed in two vectors: PGEX-4T-1 (as a 
GST-fusion protein) and in pET (as a HIS-tagged protein). giNOS specific serum 
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(generated against an immunogenic C-terminal peptide) recognized the GST-giNOS 
fusion and His-tagged giNOS as proteins of approximate molecular masses of 90 and 77 
kDa. These numbers match the predicted molecular masses of 92.6 and 69.1 kDa for the 
above mentioned (fusion) proteins. These facts confirm that the produced serum is 
specific for the postulated Giardia NOS. The serum reacted with several proteins in 
Giardia protein lysates. The strongest signal showed bands of approximately 30, 44, 46, 
and 50 kDa in trophozoites (Fig. 27). The band of 46 kDa was also present in the protein 
lysate of cells encysting for 24 h. In addition there was also a band of approximately 37 
kDa specific for 24 h-induced cells. The signal generated by this anti-serum was mostly 
associated with the particulate fraction of the protein samples. The weak bands observed 
in Western blots were lost when the serum was diluted 2000 fold (Fig. 27). 
However, none of these numbers match the predicted molecular mass for giNOS, 
66.6 kDa. IFA using giNOS-specific serum resulted in a punctate pattern signal that was 
spread in the cytosol of the cells encysting for 6, 12, and 18 h and localized mostly to the 
periphery of the trophozoites and 24 h-encysting cells. Incubation of giNOS-specific 
serum with varying concentrations of the immunogenic peptide out-competed the signal 
generated by the GST fusion- and His-tagged-giNOS, but not the signal in Giardia 
protein samples. The results obtained demonstrate that the signal registered by anti-
giNOS serum is specific for the cloned ORF but cross reacts with Giardia protein 
samples and cells in a non-specific manner. It is possible that the level of expression of 
the protein is so low that it is below the detection level. The use of semi-quantitative RT-
PCR with the giNOS specific primers showed a very low level of expression when 
compared to the expression of the inducible GNP and the constituvely expressed GDH 
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used as a standard (Fig. 31). The radioactive assay based on arginin econversion to 
citrulline did not detect NOS activity in Giardia protein lysates. The conversion of 
arginine was the same with or without NADPH and insensitive to the addition of a NOS 
inhibitor. Therefore, the assay detected only activity obtained from arginine deaminase. It 
is possible that the gene encoding the protein in non-functional, which is characteristic of 
many Giardia genes (Jerlström-Hultqvist et al., 2010; Vanacova et al., 2003). Precise 
analysis of the ORF annotated in Giardia data base as giNOS revealed that it encodes 
only the reductase domain of a typical iNOS. A Blast search of the Universal Protein 
Resource Knowledgebase (UniProtKB) with Giardia ―NOS‖ sequence identified 
Pyruvate: oxidoreductase and NADPH-cytochrome P450 reductase as the closest 
analogous proteins (Jain et al., 2009).  
Does NO-synthesizing activity in Giardia come from a protein? The presence of an 
NO-synthesizing activity in Giardia was investigated using DAF-2 to measure NO 
production in protein samples. To optimize the search for such an activity, a mixed 
protein lysate of trophozoites and cells induced to encyst for 6 h was fractionated using 
Sephadex G-150. The NO-synthesizing activity in the fractions was measured and 
appeared to elute at a relatively low molecular weight of the proteins (not shown). The 
fractions showing the highest activity were pooled to evaluate if the activity was protein-
based: heat sensitive and a distinct pH optimum suggested protein involvement. The 
intriguing observation was that the activity was not dependant on external arginine. This 
observation is in conflict with an observation earlier showing an arginine-dependent 




So far proteins associated NO production was demonstrated in Giardia trophozoites 
and encysting cells; however, the protein/proteins responsible for this activity have not 
been identified. The gene annotated as giNOS in the Giardia database encodes the 
reductase domain only. Examples of NO-producing activity with NOS carrying only 
oxygenase domains are known in bacteria. Some bacterial cells can use a cellular redox 
partner (for instance flavoprotein reductase) to cooperatively produce NO (Gusarov et al., 
2008; Zemojtel et al., 2003). However, the RT-PCR registered only a low level of 
expression of this so called ―giNOS‖ in trophozoites and encysting cells, suggesting a 
low expression level of the gene. The crude protein fractionation showed NO production 
independent of arginine. This could be explained by a tight binding of internal arginine to 
the enzyme/enzymes complex. The other possibility is that the enzyme is using internal 
arginine and converts it to citrulline, which was shown earlier for ADI by Touz et al. 
(2008). The function of the giNOS gene has to be studied in more detail and the 
protein/protein complex responsible for the NO production in Giardia has to be purified 
further. Preliminary observations have indicated that DEAE-Sephadex fractionation and 
hydroxylapatite column chromatography purifies this activity further and keeps the 













GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE 
INTRODUCTION 
 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) is a key enzyme in glucose 
metabolism. It catalyses the reversible oxidation of D-glyceraldehyde 3-phosphate into 1, 
3-bisphosphoglycerate (Harris and Water, 1976). Due to its central role in metabolism the 
GAPDH-coding gene is considered a housekeeping gene, hense constitutively expressed 
(Yang et al., 2002). As an active glycolytic enzyme, GAPDH is isolated as a tetramer 
comprised of four 37 kDa subunits. Each monomer has a binding site for NAD
+
 (amino 
acids 1-150) and glyceraldehyde-3-phosphate (amino acids 151 - 335) (Sirover, 1999). 
Catalytic activity of the enzyme is dependent on the amino acid cysteine (position 150) 
that acts in conjunction with a histidine in position 176. The catalytic cysteine is highly 
conserved from one species to another. It could be found at position 149 in E. coli, 150 in 
rat, and 152 in human (Souza and Radi, 1998; Hara and Snyder, 2006). E. coli has two 
gap genes, designated: gap A and gap B. The Gap A protein is the only active enzyme in 
E. coli, and it is more similar to eukaryotic than eubacterial GAPDH. The gap B gene is 
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expressed at a very low level and its protein product has D-erythrose 4-phosphate 
dehydrogenase (E4PDH) activity (Yang et al., 2002). In the last decade it became clear 
that multiple copies of gap genes in higher eukaryotes exist, that earlier were overlooked, 
in fact they have various intracellular activities beyond its role in glycolysis. Among 
them are membrane-membrane fusion, modulation of the cytoskeleton, binding and 
transportation of heme, DNA repair and replication, apoptosis, transcriptional activation 
and tRNA transport (Tisdale et al., 2007; Brüne and Lapetina, 1995; Chakravarti et al., 
2010). For instance, human liver GAPDH has protein kinase and ADP-ribosyl transferase 
activities, while GAPDH in human lung carcinoma cells is involved in telomere 
maintenance (Alvarez et al., 2007). The localization and differential expression of 
GAPDH in higher eukaryotes is dependent on the developmental stage of the cell 
(Tisdale et al., 2004). Recent analysis of the GAPDH sequence reveals several motifs 
with partial homology to a nuclear localization signal (KKVVK, amino acids 259-263), 
and to a nuclear export domain (ALQNIIP, amino acids 202-208) (Sirover, 1999).  
Newly described activities of GAPDH depend on the change in cellular localization 
(possibly due to structural signals) and its post-translational modification due to 
interaction with compartment-specific proteins (Sirover, 1999). Indeed GAPDH is 
potentially phosphorylated, glutathionylated, nitrated, mono-, and poly-ADP-ribosylated. 
As an example, phosphorylation at Tyr 41 in human GAPDH (modification occurs upon 
recruitment to the ER-Golgi intermediate compartment) allows it to bind to Ras-related 
small GTPase Rab2 and protein kinase C and secure the latter to the membrane. This 
recruitment plays an important role in membrane trafficking between the ER and the 
Golgi apparatus (Tisdale et al., 2004; Tisdale, 2007). GAPDH was identified as a major 
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S-glutathionylated protein in activated monocytes and endothelial cells undergoing 
oxidative stress (Mohr et al., 1999). Possibility of nitration of Tyr 311 and Tyr 317 upon 
oxidative stress with subsequent loss of glycolytic activity was also demonstrated 
(Palamalai and Miyagi, 2009).  
The catalytic cysteine makes GAPDH vulnerable to oxidation. Its activity is down-
regulated by oxidative stress conditions, H2O2, NO, as well as by interaction with NO 
intermediates (i.e. peroxynitrite anion) and S-nitrosothiols (i.e. S-nitrosoglutathione) 
(Mohr et al., 1999; Padgett and Whorton, 1995; Souza and Radi, 1998). Interaction of 
GAPDH with NO could result in direct oxidative modification, NO binding (S-
nitrosylation), or NO-dependent binding of NAD
+
. All NO-dependent modifications 
occur on the catalytic thiol group with subsequent enzyme inactivation (Alvarez et al., 
2007; Brüne and Lapetina, 1995; McDonald et al., 1993; Mohr et al., 1999; Sirover, 
1999; Souza and Radi, 1998). Studies on S-nitrosylated GAPDH demonstrated 
modulation of its interaction with cellular membranes (Sirover, 1999). The outcome of 
GAPDH S-nitrosylation in neuronal cells is its contact and stabilization of E3-ubiquitin 
ligase (Siah) that leads to nuclear translocation of both molecules with selective protein 
degradation (Hara and Snyder, 2006). It was shown to be important for neutrophil 
invagination during foreign particle engulfment and for inflammation control through the 
loss of its ability to bind and insert heme into inducible NO-synthase (iNOS) 
(Chakravarti et al., 2010). GAPDH was also identified among S-nitrosylated proteins in 
Arabidopsis thaliana (Lindermayr et al., 2005). 
Various functions dependent on the covalent modifications of GAPDH were also 
registered in protozoa and bacteria. For example, in E. histolytica, enteropathogenic E. 
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coli, and Streptococcus pyogenes, GAPDH was secreted upon ADP-ribosylation (Alvarez 
et al., 2007). Furthermore, GAPDH, secreted by E. histolytica trophozoites, binds 
extracellular NO and by means of that protects the parasite from being killed by oxidative 
stress (Alvarez et al., 2007). A similar function of GAPDH was registered in Leishmania 
where this protein is the main target of oxidation by NO. Amastigotes, the life stage of 
the parasite that is highly resistant to NO, over-express GAPDH (Alvarez et al., 2007). In 
some pathogens such as Candida albicans, Mycoplasma genitalium, Schistosoma bovis, 
Staphylococcus and Streptococcus sp., GAPDH was localized to the cell surface and 
declared to be responsible for binding extracellular matrix, playing a role of immunogen 
(Yang et al., 2002; Alvarez et al., 2007).  
Giardia has two putative gap genes, gap1 and gap2 (Yang et al., 2002). The ORF of 
gap1 encodes a typical GAPDH, while the gap2-encoded protein has only limited 
homology to it. Their protein products gGAP1 and gGAP2 have only 51% identity. 
Expression studies showed that gap1 is constitutively expressed in trophozoites and 
throughout encystment. At the same time gap2 expression was below detectable level in 
trophozoites, however, it dramatically increased during encystment with a maximum at 
12 h post induction. Complementation tests with E. coli deficient in GAPDH activity 
showed that gGAP1 has both GAPDH and E4PDH activities (Yang et al., 2002). 
Glyceraldehyde 3-phosphate dehydrogenase is inhibited by nitrosylation: When 
nitrosylated GAPDH binds the Siah-1 protein, which contains a nuclear localization 
signal (Hara and Snyder, 2006). This complex moves to the nucleus and GAPDH acts as 
a NO donor in transnitrosylation reactions (Kornberg et al., 2010), a totally new and 
unexpected function of GAPDH. Also, GAPDH inactivation by nitrosylation has been 
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reported (Mohr et al., 1999; Padgett and Whorton, 1995; Souza and Radi, 1998). 
Nitrosylation of GAPDH is possible because the catalytic cysteine in the active site 
(position 152 in human GAPDH) is close to a histidine, which acts as a proton acceptor 
(Mohr et al., 1999). As a result the thiol group involved in the catalytic events becomes 
more acidic, which makes it a good target for nitrosylation (Mohr et al., 1999). 
In summary, GAPDH is a pleiomorphic molecule whose function depends on the 
post-translational modification. Nitrosylation resulting in loss of dehydrogenase activity 
of the enzyme was demonstrated so far in many systems. The question we address here is 
whether gGAPDH is nitrosylated and if this modification can be responsible for the 
control of switch between glycolysis and cyst wall synthesis.   
 
MATERIALS AND METHODS 
GAPDH enzyme assay — To detect GAPDH activity, we used lysates of known 
protein concentrations from non-induced trophozoites (0 h) and trophozoites induced to 
encyst for 6, 8, 10, and 24 h. The reactions were carried out at room temperature for 20 s 
in a final volume 800 µl. Reaction mixtures contained 10 mM Tris-HCl, pH 8.5, 10 mM 
arsenate, 1 mM NAD
+ 
(Velick, 1955). The effect of NO on GAPDH activity was 
addressed by incubation of non-induced trophozoite lysates with 1, 10, and 100 nM cys-
NO for 2, 5, and 10 min. In this case, reactions were preincubated at room temperature 
and initiated by addition of 0.2 mM of substrate: glyceraldehyde 3-phosphate (Sigma). 
Cys-NO was synthesized fresh daily as described earlier (see Chapter II) and diluted with 
water to the indicated concentrations. The reagent was kept on ice in the dark prior to the 
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assay. As control, the same amount of reagents was used without the sodium nitrite and 
diluted the same way as the cys-NO. 
Initial velocity was determined as means of accumulation of NADH at 340 nm using 
a Beckman DU-64 spectrophotometer with an enzyme kinetics package. To standardize 
the reaction we used yeast GAPDH (Sigma). For enzyme kinetics, different substrate 
concentrations (0.04 - 0.2 mM) were used. Specific activity of the enzyme was 
determined using the extinction coefficient for NADH as described in the protocol for 
yeast GAPDH (Sigma).  
Western blot analysis of Giardia proteins with GAPDH-specific serum — Anti-
serum against a C-terminal Giardia GAPDH peptide (GYANKLVELAKYVGSKGCQ) 
was generated by Open Biosystems, Inc. (Huntsville, AL). Serum dilutions were tested 
(data are shown) and a dilution of 1:1000 was chosen for further assays. Samples 
subjected to the biotin - switch method, proteins recovered after capture with avidin – 
agarose as described earlier (see Chapter III), and protein lysates that were prepared fresh 
from trophozoites and cells induced to encyst for 6 h were loaded (20 µg per well) onto 
SDS-polyacrylamide gels and separated by electrophoresis. Protein samples were blotted 




GAPDH activity decreases throughout encystment: Protein samples were prepared 
by lysing cells induced to encyst for 0, 6, 8, 10, and 24 h and each was assayed for 
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GAPDH activity as described in the Materials and Methods section. The results (Fig. 32) 
showed that the specific activity of the enzyme for the conversion of glyceraldehyde 3-
phosphate decreases significantly during the first 6 – 8 h of encystment and remains at a 
low level throughout the remaining time of encystment. 
 Nitrosylation effect on GAPDH activity: All organisms studied to date have 
GAPDH with a catalytic cysteine and histidine (indicated with red circles on the figure) 
that are highly conserved (Fig. 33). The histidine acts as a proton acceptor and changes 
the thiol group of the catalytic cysteine into a nucleophile that attacks the carbonyl carbon 
of the substrate glyceraldehyde 3-phosphate and produces a thioester bond. The 
gGAPDH has a similar conserved catalytic site but also has a putative nitrosylation site at 
position C 39 (indicated with a blue circle). The catalytic cysteine (position 152 in human 
GAPDH and also position 152 in the Giardia enzyme) is a well known target of 
nitrosylation (Mohr et al., 1999; Padgett and Whorton, 1995; Souza and Radi, 1998). To 
investigate whether the gGAPDH is susceptible to nitrosylation, its activity was measured 
in Giardia lysates in the presence of increasing concentrations of cys-NO. The activities 
measured were compared to the activity in the absence of cys-NO. The decrease in 
enzyme activity is presented as percent inhibition (Fig. 34). Addition of 1 and 10 nM of 
cys-NO showed a similar degree of inhibition: 42.8 ± 13.2 and 46.4 ± 7.2 %, 
respectively, while addition of 100 nM of cys-NO inhibited 76.4 ± 14.8 % of the activity 
(Fig. 34). Higher concentrations of cys-NO (1 mM) showed a complete inhibition of 
gGAPDH activity (data not shown). Preincubation of the assay mixture (excluding 
substrate) with different concentrations of cys-NO for 2, 5 and 10 min showed significant 
inhibition of gGAPDH in a time-dependent manner even at low concentrations of the NO 
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donor. Addition of 1 nM inhibited 52.7 ± 3.8 % of the enzyme activity after 2 min, 75.5 ± 
18.5 % after 5 min, and 95.7 ± 7.4% after 10 min of preincubation (Fig. 35). The kinetic 
parameters of gGAPDH in the presence or absence of cyst-NO were determined as well. 
A significant decrease in Vmax of gGAPDH was demonstrated in the presence of the NO 
donor (based on the average of three independent measurements). Without nitrosylation 









. Measurement of the Vmax of gGAPDH at higher concentrations of 
cys-NO was not possible due to complete inhibition of the enzyme activity (not shown). 
Analysis of Giardia GAPDH: To see if Giardia GAPDH is nitrosylated in vivo, 
Western blot analysis of Giardia proteins with anti-serum generated against a peptide of 
GAPDH was performed on protein samples subjected to the biotin - switch method (Fig. 
36;  lanes 1 - 4), non - treated cell lysates (lanes 5 and 6) and proteins recovered after 
capture with avidin – agarose. The blot shows a strong signal with a protein of the 
expected size (37 kDa) and also that the amount of enzyme is the same in non – induced 
as well as in cells induced to encyst for 6 to 24 h, suggesting that the amount of enzyme 
is constant. Lanes 7 – 10 show that the same protein can be recovered after capture with 
avidin – agarose, indicating that the enzyme must have been nitrosylated in vivo. The 
protein samples were the same as used to shown nitrosylation of GNP as shown in Fig. 
10, Chapter III. Note also that the protein in lanes 5 and 6 shows a slight mobility shift as 
compared to the protein in lanes 1 to 4, which were used in the biotin – switch protocol 




Figure 32.  Specific activity of G. intestinalis GAPDH during encystment. 
Giardia cells induced to encyst for 0, 6, 8, 10, and 24 h were collected, resuspended in 
0.2% Triton X-100 and broken using Molecular grinding resin and pestles and 0.005 ml 
of each lysate was assayed to detect GAPDH activity. Total protein concentration in each 
lysate was detected separately. The measurements were converted to specific activity 
units, using NADH milimolar extinction coefficient. The presented data are an average of 



























Figure 33. Alignments of human, bacterial, and Giardia GAPDH. 
Catalytic cysteine and histidine are enclosed in red circles, another putative nitrosylation 








        
  
Figure 34.  Inhibition of Giardia GAPDH activity by different concentrations of 
cysteine-NO. Cysteine-NO at final concentrations 1, 10, and 100 nM were added to the 
reaction mixture prior to addition of the substrate. The enzyme activity was compared to 
the gGAPDH activity in the absence of cysteine-NO and the percentage inhibition was 
calculated. The presented data are an average of 3 assays, the error bars represent SD.    
 
          
Figure 35. Effect of time on the inhibition of Giardia activity by fixed concentration 
of cysteine-NO. Cysteine-NO at a fixed concentration of 1 nM was incubated with the 
reaction mixture (excluding the substrate) for 2, 5, or 10 min. The gGAPDH activity was 
measured and compared to the activity in the absence of NO donor and percentage of 

















































Figure 36. Western blot of Giardia proteins screened with anti-GADPH serum. 
Lanes 1 - 4, and 7- 10 were loaded with cell lysates treated according to the biotin-switch 
protocol, while lanes 5 and 6 with non-treated cell lysates.  Lanes 1 - 4 were loaded with 
20 μg of total protein from non-encysting trophozoites cultivated in medium with no bile 
(1) or low bile (2); trophozoites induced to encyst for 12 h (3) and 24 h (4). Lanes 5 and 6 
were loaded with 20 µg proteins from fresh cell lysates of non-induced trophozoites (5) 
and trophozoites induced to encyst for 6 h (6). Lanes 7 – 10 contain proteins recovered by 
capture with avidin-agarose. Lane 7, standard medium, lane 8, 6 h-, lane 9, 12 h- and lane 
10, 24 h- encysting cells. The blot was screened with a 1:1000 dilution of serum 












What do we know so far about GAPDH? In the last decade the view of GAPDH as a 
classical glycolytic enzyme has been changed dramatically. The changes in the protein 
functions have been associated with the change in the protein localization and/or post-
translational modification, one of which is nitrosylation (Mohr et al., 1999; Padgett and 
Whorton, 1995; Souza and Radi, 1998). Snyder and Hara (2006) showed that nitrosylated 
GAPDH binds the Siah-1 protein, which contains a nuclear localization signal, the 
complex than moves to the nucleus and GAPDH acts as a NO donor in transnitrosylation 
reactions (Kornberg et al., 2010), a totally new and unexpected function of GAPDH. 
Also, GAPDH inactivation by nitrosylation has been reported (Hara and Snyder, 2004; 
Mohr et al., 1999; Sirover, 1999). Nitrosylation of GAPDH is possible because the 
catalytic cysteine in the active site (position 152 in human GAPDH) is close to a 
histidine, which acts as a proton acceptor (Mohr et al., 1999). As a result the thiol group 
involved in the catalytic event becomes more acidic, which makes it a good target for 
nitrosylation (Mohr et al., 1999). 
Giardia GAPDH:  In Giardia this enzyme is encoded by two genes: gap1 and gap2. 
The gap1 gene encodes a protein with a typical dehydrogenase sequence and is 
constitutively expressed, while gap2 expression was below detection level in trophozoites 
and increased during encystment with a peak at 12 h and had D-erythrose 4-phosphate 
dehydrogenase activity (Yang et al., 2002). The function of this GAP2 enzyme remains 
elusive. Activity of GAPDH throughout encystment has never been studied before. 
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The findings in this studied show that the GAPDH specific activity declined after 
cells are present 6 - 8 h in encystment medium. Semi-quantitative RT-PCR showed that 
the enzyme is expressed in a constitutive manner (data not shown), which is supported by 
the results obtained by Western blot analysis with the specific anti-Giardia GAPDH 
serum. Thus, the decline in specific activity is rather associated with either a change in 
GAPDH intracellular localization or a post-translational modification. GAPDH 
susceptibility to nitrosylation with the following loss of activity in other systems suggests 
that the Giardia enzyme also could be affected by nitrosylation. A Giardia Database 
search identified a nitrosylation motif (Stamler et al., 1997) on the GAP1 protein at C 39, 
which is unique to Giardia. However, conserved in the Giardia enzyme are the 
equivalents of the catalytic C 152 and H 176 (Sirover, 1997). Addition of cys-NO to cell 
lysates inhibited gGAPDH activity (Vmax) in a dose-dependent manner and in a time-
dependent manner even at low cys-NO concentrations. So far it is not clear if both C 39 
and C 152 are modified, but the latter one seems most likely.  
As shown above, the specific activity of GAPDH goes down when the cells are 
induced to encyst. In vitro nitrosylation with cys-NO showed clearly that nitrosylation is 
able to inhibit enzyme activity as has been observed with this enzyme in many other 
systems. The results of Western blot analysis with the specific anti-serum showed very 
clearly that: 1) the amount of enzyme stays constant during encystment, in agreement 
with semi-quantitative RT-PCR, which shows that the level of GAPDH mRNA stays 
constant as well during encystment (data not shown); 2) the protein shows a slight 
mobility shift when the enzyme is compared to the one that was treated with the biotin – 
switch method, indicating the presence of a charged group that interferes with binding 
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SDS before removal of this group and replacement with biotin; and 3) that the enzyme 
can be bound to avidin-agarose when it was biotinylated. Note that the protein samples 
were the same as was used to capture GNP, which was discussed in Chapter III.  Thus 
GAPDH shows constitutive expression during encystment, appears to be nitrosylated in 
vivo and loses its activity. The conclusion must be that the enzyme’s catalytic ability is 
changed by post – translational modification and that just as is the case for GNP, 
nitrosylation acts as an allosteric control mechanism of the enzyme. The implication is 
that glycolysis will slow down at the point of the redox reaction catalyzed by this 
enzyme. Control of glycolysis at this level has been shown in ischemic kidneys. 
Inhibition of GAPDH inhibited glycolysis and anaerobic ATP production (Devalaraja-
Narashimha and Padanilam, 2009). In the case of Giardia the ADHP is present as an 
alternative source of ATP. Still the control at the level of GADPH is unusual; in studies 
that measure metabolic flux, the couple glyceraldehyde 3-phosphate dehydrogenase and 
1,3 bisphoglycerate kinase always appears to be close to equilibrium and the least likely 
to form a point of regulation (Canelas et al., 2011). Metabolic flux studies in Giardia 
would form an excellent way to study control at a branch-point of two major pathways, 













SUMMARY AND FUTURE RESEARCH 
 
The long term goal of this research is to investigate the mechanism(s) of regulation 
of Giardia intestinalis encystment. The facts that glucose in the form of F6P is used for 
energy production via glycolysis in trophozoites, uptake of glucose ceases by 6 h into the 
encystment process, and the endogenous glucose is used as a substrate for cyst wall 
synthesis in the cells undergoing encystment raises the regulatory question of how does 
Giardia regulate the flux from glucose’s bioenergetics use to its synthetic use during 
encystment. The recent discovery that Giardia synthesize NO, coupled with the role of 
this molecule in the cell cycle regulation of other systems, suggests that NO involvement 
in the regulation of this switch is possible. To date we know that Giardia synthesize NO 
and use it to modify GNP. GNP is the first enzyme in the giardan synthetic pathway. In 
vitro nitrosylation of recombinant GNP resulted in a two fold increase in the enzyme’s 
catalytic performance and there is MS evidence that GNP is nitrosylated. It is difficult to 
extrapolate these findings to the in vivo situation, however, if it is the case than 
115 
 
nitrosylation along with the increased amount of protein (due to induced expression) is 
enough to redirect F6P from glycolysis toward the cyst wall synthesis.  
There is also preliminary evidence that GAPDH is nitrosylated and down regulated 
during encystment. Findings in other systems as well as the results presented in this 
dissertation suggest that nitrosylation of GAPDH might lead to the inactivation of the 
enzyme and thus slowing down of glycolysis.  
ADHP is up-regulated during the first 6 h of encystment – the same time when NO 
production increases and protein nitrosylation is observed. It is also the time when GNP 
is first detected. The fact that ADHP is an alternative pathway for ATP production along 
with the other findings suggests that Giardia can switch, at least in part, from glycolysis 
to ADHP as an energy producing pathway during encystment. The switch between 
glycolysis and cyst wall synthesis could certainly be regulated through GAPDH 
inactivation and GNP activation by means of nitrosylation along with increased 
expression of GNP.  
Even though the source of NO in Giardia is still not clear, the putative enzyme 
detected in our fractionation is heat labile, has a pH optimum around 8 and does not 
depend on external arginine. The so-called giNOS, annotated in the Giardia database, 
cannot be responsible for NO production itself because the enzyme is missing the oxygen 
and arginine binding domains.  
The logical continuation of the current study would be purification of the NO-
synthesizing activity. This could be approached by using classical biochemical 
procedures followed by mass spectrometry of the purified protein(s). The fate of 
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nitrosylated GAPDH has to be studied further. This protein plays a role as transcriptional 
regulator in some systems as well as a guard against oxidative stress in another 
microaerophile – Entamoeba. Primarily, the localization of the protein during encystment 
has to be determined to explore the function of nitrosylated GAPDH. In addition, the 
protein should be studied by over-expression and down-regulation in transfection studies.  
Although GNP is transcriptionally activated and appears to be regulated by a single 
ubiquitin attachment, the further fate of nitrosylated and uniquitinated GNP is not known. 
The increased amount of peptides reacting with GNP-specific serum in the cells induced 
to encyst for long periods of time suggests proteasomal degradation. Studies inhibiting 
proteasomal activity could give an answer to the question of degradation and its effect. In 
addition it is possible that the protein is subjected to phosphorylation and/or 
SUMOylation. This question could be addressed by application of SUMO-specific 
antibodies and antibodies specific for phosphorylated serine and threonine in Western 
blot analysis. Upon confirmation of any of the mentioned modifications the following 
step would be to establish if modification precedes or competes with a single ubiquitin 
attachment. 
 The Giardia database shows three single ubiquitin- and one SUMO-coding gene. In 
preliminary studies (data not shown), all four genes are expressed. However, comparative 
expression of all four genes upon encystment was never addressed. The proteasomal 
activity was also never studied in encysting cells. Due to the fact that ubiquination along 
with SUMOylation are often used in gene/protein regulation it is interesting to assess 
these modifications and their role in the encysting cells. 
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In conclusion, because Giardia is a relatively simple organism as discussed in 
Chapter I and has a minimal genome, some of the questions raised about metabolic flow 
and redirection of pathways by enzyme amounts and protein modifications make this 
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